EurekaMag Full Text Articles Chapter 34,416

Rebibou, J.M.; Bittencourt, M.C.; Ducloux, D.; Chabod, J.; Thevenin, C.; Chalopin, J.M.; Herve, P.; Tiberghien, P. 2000: Anti-class II antibodies in kidney transplant patients. Transplantation Proceedings 32(8): 2748-2749

Wise, M.A.; Moorehead, H.R.bert 2001: Anti-clotting methods and apparatus for indwelling catheter tubes. Official Gazette of the United States Patent and Trademark Office Patents 1249(1)

Ranby, M. 2002: Anti-coagulation of blood, plasma or synovial fluid products using iso-citrate. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)

Landry, D.W. 1999: Anti-cocaine catalytic antibody. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)

Wirsching, P.; Janda, K.D. 2002: Anti-cocaine vaccine. Official Gazette of the United States Patent and Trademark Office Patents 1258(1)

Wengrowicz, S.E.; Blanchard, M.E.; Rodriguez Alvare, F.R.; Guardia, E.; Fabra, J.M.; De Leiva, A.; Wall, J.R. 2000: Anti-collagen XIII antibodies are markers of thyroid eye disease outcome following methylprednisolone treatment. Endocrine Journal 47(Suppl August): 195

Cojocaru, M.; Mirela Mitrea, C.; Mircea Cheta, D. 1999: Anti-collagen autoantibodies in insulin-dependent diabetes mellitus. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S482

Jordan, J.E.; Morrissey, M.; Stahl, G.L. 2000: Anti-complement treatment protects hypoxic reoxygenated HUVECs from apoptosis. Immunopharmacology 49(1-2): 24

Ueno, R. 2002: Anti-constipation composition. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)

Aldarmaa, J.; Liu, Z.; Long, J.; Mo, X.; Ma, J.; Liu, J. 2010: Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction. Neurochemical Research 35(1): 33-41

Harling, J.D.; Orlek, B.S.; Thompson, M. 2001: Anti-convulsant isoquinolyl-benzamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1249(3)

Kawano, K.; Kitsukawa, H. 2000: Anti-cornea-collapsing device for ophthalmic surgery using ultra-high vacuum aspiration. Official Gazette of the United States Patent and Trademark Office Patents 1232(4)

O'brien, C. 2001: Anti-craving medications A new target for pharmacotherapy?. AAAS Annual Meeting and Science Innovation Exposition 167: A4, February 15-20

Marino, M. 2000: Anti-creeping cap for container. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Pettit, G.R.; Pettit, R.K. 2003: Anti-cryptococcal peptides. Official Gazette of the United States Patent and Trademark Office Patents 1274(3)

Boyd, M.R.; Gustafson, K.R.; Shoemaker, R.H.; Mcmahon, J.B. 1999: Anti-cyanovirin antibody. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Stewart, S.F.; Vidali, M.; Haugk, B.; Albano, E.; Burt, A.; Jones, D.E.J.; Day, C.P. 2004: Anti-cytochrome P4502E1 autoantibody titre associates with immune liver histology in advanced alcoholic liver disease. Gut 53(Suppl 3): A13

Hillarby, M.; Reynolds, I.; John, S.L.; Holt, L.; Tullo, A.B. 1999: Anti-cytokeratin antibodies are associated with peripheral ulcerative keratitis in Wegeners granulomatosis. IOVS Investigative Ophthalmology and Visual Science 40(4): S556

Martyushev, A.V.; Sherstoboev, E.J.; Pashinskiy, V.G.; Sergeeva, S.A.; Epstein, O.I. 2002: Anti-cytokine antibodies in ultralow doses regulate cytokine expression Experimental and clinical aspects. Journal of Interferon and Cytokine Research 22(Suppl 1): S-122

Steinmeyer, J. 2003: Anti-cytokine based therapy of osteoarthritis. Aktuelle Rheumatologie 28(6): 316-321

Neumann, E.; Judex, M.; Kullmann, F.; Pap, T.; Robbins, P.D.; Evans, C.H.; Gay, S.; Schoelmerich, J.; Mueller Ladner, U. 2000: Anti-cytokine double gene transfer in the SCID mouse model. Immunobiology 203(1-2): 483

Auten, R.L.; Deng, H. 1999: Anti-cytokine induced neutrophil chemoattractant-1 treatment reduces neutrophil accumulation in hyperoxia exposed newborn rat lung. Pediatric Research 45(4 Part 2): 294A

Auten, R.L.; Mason, S.N.; Tanaka, D.T. 2000: Anti-cytokine neutrophil chemoattractant-1 treatment prevents adverse effects of hyperoxia on newborn rat lung. Pediatric Research 47(4 Part 2): 351A

Dinarello, C.A. 2003: Anti-cytokine therapies for inflammatory diseases Present and future. Vaccine 21(Suppl 2): S2/24-S2/34, 1 June

Taylor, P.C. 2003: Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Current Pharmaceutical Design 9(14): 1095-1106

Dinarello, C.A. 2002: Anti-cytokines therapies. Journal of Interferon and Cytokine Research 22(Suppl 1): S-42

Dunlop, D.S.; Guskey, S.M.; Leyba, V.E.; Royce, D.A. 2002: Anti-dandruff and conditioning shampoos containing polyalkylene glycols and cationic polymers. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

James, B.O.; James, I.B. 1999: Anti-decubitus pneumatic mattress. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)

Hirai, S. 2000: Anti-dementia drugs for the treatment of Alzheimers disease. Japanese Journal of Pharmacology 82(Suppl 1): 30P

Watanabe, H. 2000: Anti-dementia effects of traditional medicine. Phytomedicine 7(Suppl 2): 62

Holt, J.D. Schwarz; Young, W.M.; Chang, K.J.; Gengo, P.J. 2003: Anti-depressant effects of acute delta opioid agonist BW373U86 in the modified forced swim test a comparison with acute and chronic buproprion and desipramine. FASEB Journal 17(4-5): Abstract 644

Redei, E. 2002: Anti-depressant effects of corticotropin release inhibiting factor. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Sztajnkrycer, M.D.; Gesell, L.B.; Dewan, N. 1999: Anti-depressant overdoses presenting to a regional toxicology referral emergency department over a five year period. Journal of Toxicology. Clinical Toxicology 37(5): 633

Kwo, P.Y.; Neustater, B.R.; Stelzer, F.A.; Hudes, B.K.; Pound, D.C.; Santoro, J.J.; Aycock, R.S.; Grunvald, E.R.; Musick, B.; Eckert, G. 2003: Anti-depressant use in patients receiving interferon alfa and ribavirin for chronic hepatitis C. Hepatology 38(4 Suppl 1): 750A

Ruenberg, D. 2002: Anti-depressant, stress suppressor and mood improver. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)

Nagasaka, T.; Nishifuji, K.; Ota, T.; Whittock, N.V.; Amagai, M. 2004: Anti-desmoglein 4 IgG autoantibodies are not directly involved in blister formation in pemphigus. Journal of Dermatological Science 34(2): 120

Hiramoto, T.; Saiki, K.; Masumura, S.; Shimizu, T.; Yamashita, T.; Kaneko, N.; Maruta, Y. 2002: Anti-deterioration agent for food flavors, method for preventing deterioration of food flavors, and foods containing anti-deterioration agent for food flavors. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)

Xiang, Z.; He, F.; Kang, T-Guo.; Dou, D-Qiang.; Gai, K.; Shi, Y-Yuan.; Kim, Y-Ho.; Dong, F. 2010: Anti-diabetes constituents in leaves of Smallanthus sonchifolius. Natural Product Communications 5(1): 95-98

Nguyen, H.K.; Dao, P.V.; Nguyen, T.D.; Nguyen, H.G.T.; Ostenson, C.G. 2003: Anti-diabetic activity of the plant Anemarrhena asphodeloides comprises stimulation of insulin secretion in islets of diabetic GK and control rats. Diabetes and Metabolism 29(Hors serie 2): 4S271-4S272

Rao, J.M.; Sumathykutty, M.A.; Nair, G.V.; Damodaran, A.D.; Rathinam, K.; Sivakumar, R.; Das, K.M.; Nair, N.V. 2003: Anti-diabetic agent obtained from the plant Humboldtia decurrens and a process for preparing the same. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Satoh, N.; Masuzaki, H.; Ebihara, K.; Matuoka, N.; Aizawa Abe, M.; Ogawa, Y. 1999: Anti-diabetic effect of leptin is mediated through hypothalamic melanocortin system in transgenic skinny mice overexpressing leptin. Diabetes 48(Suppl 1): A26

Rosenthal, M.J.; Song, M.K. 2000: Anti-diabetic effects of cyclo are mediated via regulation of zinc metabolism in rats. FASEB Journal 14(4): A737

Ryder, J.; Bauman, D.; Portocarrero, C.; Song, X.; Yu, M.; Barbano, D.; Zierath, J.; Houseknecht, K. 1999: Anti-diabetic effects of dietary conjugated linoleic acid Isomer-specific effects on glucose tolerance and skeletal muscle glucose transport. Journal of Animal Science 77(Suppl 1): 119

Zinker, B.; Xie, N.; Clampit, J.; Nguyen, P.; Wilcox, D.; Jacobson, P.; Crosby, S.; Rondinone, C.; Butler, M.; Murray, S.; Mckay, R.; Bhanot, S.; Monia, B.; Reilly, R.; Opgenorth, T.; Trevillyan, J.; Jirousek, M. 2001: Anti-diabetic effects of protein tyrosine phosphatase 1B antisense treatment in a rodent model of diabetes Potential therapeutic benefit. Diabetes 50(Suppl 2): A332

Wagman, A.S.; Harrison, S.D.; Johnson, K.; Ring, D.B.; Bussiere, D.E.; Nuss, J.M.; Pfister, K.B.; Goff, D.; Boyce, R.S.; Ramurthy, S.; Brown, S.P.; Renhowe, P.A.; Subr 2003: Anti-diabetic glycogen synthase kinase 3 inhibitors In vitro and in vivo activity. Abstracts of Papers American Chemical Society 225(1-2): MEDI 22

Beeley, N.R.bert Arnold; Prickett, K.S. 2000: Anti-diabetic peptides. Official Gazette of the United States Patent and Trademark Office Patents 1236(2)

Reyes, B.; Bautista, N.; Tanquilut, N.; Anunciado, R.; Leung, A.; Sanchez, G.; Magtoto, R.; Sajapitak, S.; Tsukamura, H.; Maeda, K.I. 2003: Anti-diabetic potentials of Momordica charanta and Andrographis paniculata and their effects on estrous cyclicity of Alloxan-induced diabetic rats. Journal of Animal Science 81(Suppl 2): 46

Reyes, B.; Bautista, N.; Magtoto, R.; Tanquilut, N.; Leung, A.; Battad, Z.; Sanchez, G.; Anunciado, R.V.; Tsukamura, H.; Maeda, K.I. 2003: Anti-diabetic potentials of Momordica charanta and Andrographis paniculata and their effects on estrus cyclicity of Alloxan-induced diabetic rats. Journal of Dairy Science 86(Suppl 1): 248

Greenblatt, H.C.; Adalsteinsson, O.; Brodie, D.A.; Jacoby, H. 2004: Anti-diarrheal and method for using the same. Official Gazette of the United States Patent and Trademark Office Patents 1287(2)

Kashanian, S.; Rasaee, M.J.; Paknejad, M. 2002: Anti-digoxin monoclonal antibody. Hybridoma and Hybridomics 21(3): 219

Keung, W.M. 2003: Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence. Medicinal Research Reviews 23(6): 669-696

Abdelnoor, A.M.; Shrayteh, Z.; Khauli, R.; Daouk, M.; Habbal, A.; Medawar, W. 2004: Anti-donor and anti-non-donor HLA antibodies post-transplantation in sera of kidney allograft recipients. Genes and Immunity 5(Suppl 1): S33

Siegel, R.; Klohe, E.; Eklund, D. 2003: Anti-donor antibody quantitation for pre- and post-transplant monitoring of a 100% PRA heart recipient. Human Immunology 64(Suppl 1): S67

Newton, B.L.; Cote, A.L.S.; Ganem, C.F.; Castanon, S. 2004: Anti-drawback medical valve. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)

Hirai, K.; Nagata, K.; Koyama, J.; Kishimoto, T. 2002: Anti-drug resistant strain agents and antichlamydia agents. Official Gazette of the United States Patent and Trademark Office Patents 1258(4)

Mesa, L.J.; Herndon, B.L.; Siddiqi, I.; Willsie, S.K. 2000: Anti-dsDNA IgG titer in bronchoalveolar lavage correlates with early deaths in persons with AIDS. FASEB Journal 14(6): A939

Villalta, D.; Romelli, P.; Barbieri, L.; Doria, A.; Ghirardello, A.; Tozzoli, R.; Bizzaro, N.; Tonutti, E. 2001: Anti-dsDNA antibodies avidity measured by ELISA method as a useful tool in the diagnosis of SLE. Clinical Chemistry 47(S6): A46

Hernando, M.; Gonzalez, C.; Sanchez, A.; Guevara, P.; Navajo, J.A.; Gonzalez Buitrago, J.M.; Papisch, W. 2001: Anti-dsDNA antibodies in SLE Clinical evaluation of an ELISA and a new enzyme immunoassays on an automated platform, both using recombinant plasmid dsDNA. Lupus 10(Suppl 1): S126

Weinberg, I.; Vasiliev, L.; Gotsman, I. 2000: Anti-dsDNA antibodies in sarcoidosis. Seminars in Arthritis and Rheumatism 29(5): 328-331

Ho, A.; Magder, L.; Petri, M. 1999: Anti-dsDNA drops at time of SLE flare. Arthritis and Rheumatism 42(9 Suppl): S96

Naiki, M. 2001: Anti-edema agent. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)

Polanska, B.; Jankowski, A.; Korpanty Danda, J.; Niemczuk, M.; Jesionkowska, M. 2000: Anti-elastin antibodies and anti-neutrophil elastase antibodies in rheumatoid arthritis patients. Immunology Letters 73(2-3): 156-157

Brown, C.L. 2000: Anti-embolism stocking device. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)

Horikoshi, K.; Yokoyama, T.; Kishibayashi, N.; Ohmori, K. 2000: Anti-emetic activities of 5-HT3 receptor antagonists against high-dose cisplatin-induced emesis in Suncus murinus. Japanese Journal of Pharmacology 82(Suppl 1): 277P

Huckle, R.M.; Tuladhar, B.R.; Naylor, R.J. 2002: Anti-emetic effect of tramadol. British Journal of Pharmacology 135(Proceedings Suppl): 362P

Hallwood, P.M.; Barkby, G.D. 2000: Anti-emetic pharmaceutical compositions containing methotrimeprazine. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)

Kraut, L.; Fauser, A.A. 2001: Anti-emetics for cancer chemotherapy-induced emesis: Potential of alternative delivery systems. Drugs 61(11): 1553-1562

Seon, B.K. 1999: Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy. Official Gazette of the United States Patent and Trademark Office Patents 1224(4)

Shiozaki, K.; Harada, N.; Greco, W.R.; Tsai, H.; Seon, B.K. 2003: Anti-endoglin monoclonal antibody for antiangiogenic and vascular targeting therapy of cancer Parmacokinetics and immunogenicity of human/mouse chimeric anti-endoglin mAb in non-human primates. Proceedings of the American Association for Cancer Research 44: 600

Harada, N.; Shiozaki, K.; Haba, A.; Buitrago, S.; Martin, L.; Seon, B.K. 2003: Anti-endoglin monoclonal antibody for antiangiogenic and vascular targeting therapy of cancer Toxicity testing of a human/mouse chimeric anti-endoglin mAb in non-human primates. Proceedings of the American Association for Cancer Research 44: 600-601

Haba, A.; Takahashi, N.; Norderhaug, L.; Seon, B.K. 2001: Anti-endoglin monoclonal antibody for antiangiogenic therapy Comparison of IgG1 and IgG3 human/mouse chimeric antibodies and the parental monoclonal antibody. Proceedings of the American Association for Cancer Research 42: 823

Sabbatella, L.; Di Tola, M.; Di Giovambattista, F.; Di Cello, T.; Gabrielli, F.; Greco, R.; Anania, M.C.; Mastracchio, A.; Caprilli, R.; De Vincenzi, M.; Picareli, A. 1999: Anti-endomysial antibodies of IgG1 isotype. Immunology Letters 69(1): 103

Dahele, A.; Kingstone, K.; Bode, J.; Anderson, D.; Ghosh, S. 2000: Anti-endomysium antibody negative coeliac disease Does additional serological testing help?. Gut 46(11): A48

Tsuboi, S.; Manabe, K.; Ohmori, H.; Tomono, Y.; Naito, I.; Miyazaki, M.; Ninomiya, Y.; Nouso, K.; Nakatsukasa, H.; Higashi, T.; Tsuji, T. 2001: Anti-endostatin monoclonal antibody inhibits antiangiogenic activity of endogenous endostatin secreted from human hepatocellular carcinoma xenografted in nude mice and promotes growth of the tumor by suppression of apoptosis. Hepatology 34(4 Pt 2): 387A

Tsuboi, S.; Manabe, K.; Ohmori, H.; Tomono, Y.; Naito, I.; Miyazaki, M.; Ninomiya, Y.; Nouso, K.; Nakatsukasa, H.; Higashi, T.; Tsuji, T. 2002: Anti-endostatin monoclonal antibody inhibits endogenous endostatin secreted from human hepatocellular carcinoma xenografted in nude mice and promotes the growth of the tumor itself. International Journal of Cancer Suppl (13): 130

Lakos, G.; Kiss, E.; Szollosi, I.; Balla, G.; Balla, J.; Sipka, S.; Szegedi, G. 2000: Anti-endothelial and anti-beta2-glycoprotein I antibodies in systemic lupus erythematosus patients with thrombosis A comparative study. Journal of Autoimmunity 15(2): A89

Meroni, P.L.; Elena, E.R.; Cinzia, T.; Borghi, M.O. 2000: Anti-endothelial antibodies Characterization and pathogenetic role. Clinical and Experimental Immunology 120(Suppl 1): 4-5

Foschi, F.G.; Zoli, G.; Castelli, E.; Addolorato, G.; Parazza, M.; Loggi, E.; Capristo, E.; Trevisani, F.; Gasbarrini, G.; Stefanini, G.F.; Bernardi, M. 1999: Anti-endothelial antibodies and CD30s in patients with inflammatory bowel disease. Gastroenterology 116(4 Part 2): A717

Gomez, H.F.; Herrera Insua, I. 2000: Anti-endothelial autoantibodies from healthy adults injure human umbilical vein endothelial cells. Pediatric Research 47(4 Part 2): 263A

Farsi, A.; Domeneghetti, M.P.; Brunelli, T.; Gori, A.M.; Fedi, S.; Giglioli, C.; Falai, M.; Lombardi, A.; Chioccioli, M.; Abbate, R. 1999: Anti-endothelial cell antibodies A marker of the immune system activation in unstable angina and a new risk factor for restenosis after percutaneous transluminal coronary angioplasty. European Heart Journal 20(ABSTR Suppl ): 395

Azeka, E.; Mendonca, L.L.F.; Cossermelli Messina, W.; Bonfa, E.; Khamashta, M.; Hughes, G.R.V. 1999: Anti-endothelial cell antibodies Marker of ongoing disease activity in systemic lupus erythematosus. Arthritis and Rheumatism 42(9 Suppl): S149

Suberbielle Boissel, C.; Peraldi, M.N.; Legendre, C.; Boissel, N.; Meshaka, G.; Guekam Moumi, A.; Morelon, E.; Kreis, H.; Charron, D. 2001: Anti-endothelial cell antibodies after kidney transplantation. European Journal of Immunogenetics 28(2): 257

Amor-Dorado, J.C.; García-Porrua, C.; Gonzalez-Gay, M.A. 2002: Anti-endothelial cell antibodies and biopsy-proven temporal arteritis. Lupus 11(2): 134

Bloom, B.J.; Toyoda, M.; Petrosyan, A.; Alario, A.J.; Jordan, S.M. 2002: Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis and may induce endothelial activation. Pediatric Research 51(4 Part 2): 12A

Rotiroti, G.; Godfrey, T.; Mendonca, L.L.F.; Khamashta, M.; Hughes, G.R.V. 1999: Anti-endothelial cell antibodies in Wegeners granulomatosis. Arthritis and Rheumatism 42(9 Suppl): S317

Horvathova, M.; Jahnova, E.; Nyulassy, S. 2002: Anti-endothelial cell antibodies in patients with connective tissue diseases and modulation of adhesion molecule expression on cultured endothelial cells. Lupus 11(9): 575

Hancock, R.E.W.; Gough, M.A.; Patrzykat, A.; Woods, D.; Jia, X. 2001: Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor. Official Gazette of the United States Patent and Trademark Office Patents 1250(2)

Kao, R.; Newman, M.; Moretti, E.; Tsuno, M.; Perdomo, C.; Lynn, M.; Rossignol, D.P. 2002: Anti-endotoxin IgM as a predictor of clinical outcome from coronary artery bypass graft surgery. Journal of Endotoxin Research 8(3): 216-217

Pratesi, F.; Moscato, S.; Chimenti, D.; Bongiorni, F.; Bombardieri, S.; Madaio, M.P.; Migliorini, P. 2001: Anti-enolase antibodies and nephritis. Lupus 10(Suppl 1): S95

Shah, N.F.; Dyett, L.; Smith, V.V.; Lindley, K.J.; Milla, P.J. 2000: Anti-enterocyte antibodies with terminal ileitis predict the development of chronic pouchitis after ileal pouch-anastomosis. JPGN 31(Suppl 2): S160

Chern, J.H.; Shia, K.S.; Shih, S.R.; Hsu, T.A.; Tai, C.L. 2004: Anti-enterovirus compounds. Official Gazette of the United States Patent and Trademark Office Patents 1288(2)

Reed Clark, K.; Johnson, P.R. 1999: Anti-env immune responses in rhesus macaques elicited by rAAV vectors encoding SIVgp160. Journal of Medical Primatology 28(4-5): 304

Berkun, Y.; Sade, K.; Ulmansky, R.; Levi Schaffer, F.; Naparstek, Y. 2002: Anti-eosinophil peroxidase A new marker for Churg-Strauss syndrome. Journal of Allergy and Clinical Immunology 109(1 Suppl): S280

Fal, A.M.; Leopold, D.A.; Beck, L.A.; Bickel, C.A.; Nutku, E.; Hamid, Q.; Schleimer, R.P. 1999: Anti-eosinophilic effects of IL-12 and IL-18 in human nasal polyp tissue. Journal of Allergy and Clinical Immunology 103(1 Part 2): S55

Lammering, G. 2003: Anti-epidermal growth factor receptor strategies to enhance radiation action. Current Medicinal Chemistry. Anti-Cancer Agents 3(5): 327-333

Patsalos, P.N. 2000: Anti-epileptic drug monitoring and interactions in epileptic therapy. British Journal of Pharmacology 131(Proceedings Suppl): 135P

Jacobson, M.P.; Khurana, D.S. 2000: Anti-epileptic drug prescription plan problems The Philadelphia story. Epilepsia 41(Suppl 7): 110

Fonager, K.; Larsen, H.; Pedersen, L.; Sørensen, H.T. 2001: Anti-epileptic drugs and intrauterine growth. Acta Neurologica Scandinavica 104(5): 323-324

Leker, R.R.; Neufeld, M.Y. 2003: Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Research. Brain Research Reviews 42(3): 187-203

Caleo, M.; Costantin, L.; Richichi, C.; Viegi, A.; Funicello, M.; Gobbi, M.; Mennini, T.; Rossetto, O.; Montecucco, C.; Maffei, L.; Vezzani, A.; Bozzi, Y. 2004: Anti-epileptic effects of botulinum toxin E. Epilepsia 45(Suppl 3): 55

Nekrassov, V.; Sitges, M. 2001: Anti-epileptic potential of vinpocetine. Journal of Neurochemistry 78(Suppl 1): 98

Weaver, D.E.; Milne, P.H.; Tan, C.Y.K.; Carran, J.R. 2001: Anti-epileptogenic agents. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)

King, C.R.; Kraus, M.H.; Aaronson, S.A. 2003: Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor. Official Gazette of the United States Patent and Trademark Office Patents 1276(4)

Gast, M.J.; Miller, C.P. 2001: Anti-estrogen plus progestin containing oral contraceptives. Official Gazette of the United States Patent and Trademark Office Patents 1253(1)

Robertson, J.F.R.; Wilsher, P.C.; Kenny, F.; Ellis, I.O.; Pinder, S.; Nicholson, R.I. 2002: Anti-estrogen therapies and estrogen receptor expression in breast cancer. Journal of Clinical Ligand Assay 25(1): 120-121

Schreurs, R.; Legler, J.; Lanser, P.; Seinen, W.; V.D. Burg, B. 2003: Anti-estrogenic activity of polycyclic musks in the zebrafish. Toxicological Sciences 72(S-1): 135

Tanabe, M.; Peters, R.H.; Chao, W.R.; Jong, L. 2003: Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1269(3)

Arzamastsev, A.P.; Vorontsova, N.S. 2003: Anti-estrogens Nomenclature, properties, and pharmacopoeia-based analysis. Khimiko-Farmatsevticheskii Zhurnal 37(5): 33-38

D.S., J.A.; Davis, J.H.; Bowen, D. 2002: Anti-estrogens antagonize the anti-proliferative effects of methotrexate in human breast cancer. FASEB Journal 16(4): A178

Antus, B.; Liu, S.; Yao, Y.; Zou, H.; Song, E.; Lutz, J.; Heemann, U. 2001: Anti-estrogens promote chronic allograft nephropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 852A

Chetrite, G.; Pasqualini, J. 1999: Anti-estrone sulfatase activity in human breast cancer cells. Breast Cancer Research and Treatment 57(1): 53

Mesfin, F.B.; Andersen, T.T.; Jacobson, H.I.; Zhu, S.; Bennett, J.A. 2000: Anti-estrotrophic and anti-breast cancer activity of an AFP-derived octapeptide. Proceedings of the American Association for Cancer Research 41: 375

Blackburn, M.N.; Church, W.R.; Feuerstein, G.Z.; Gross, M.S.; Nichols, A.J.; Padlan, E.A.; Patel, A.H.; Sylvester, D.R. 2002: Anti-factor IX/IXa antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)

Kaveri, S.V.; Moreau, A.; Lacroix Desmazes, S.; Stieltjes, N.; Saenko, E.; Scandella, D.; Kazatchkine, M.D. 2000: Anti-factor VIII antibodies that neutralize FVIII procoagulant activity, are present in plasma of non-responder patients with severe hemophilia A and in normal human IgG. FASEB Journal 14(6): A1106

Anonymous 2001: Anti-Ferritin. Hybridoma 20(1): 73

Takeshita, A.; Mitamura, H.; Sato, T.; Shinagawa, K.; Kurita, Y.; Kanki, H.; Takatsuki, S.; Hara, M.; Ogawa, S. 2000: Anti-fibrillatory effects of a pure IKr blocker, E4031 and a combined IKr+IKs blocker, azimilide in the pacing-induced remodelled atrium. European Heart Journal 21(Abstract Suppl): 123

Hanai, N.; Yamasaki, M.; Furuya, A.; Tanaka, A. 1999: Anti-fibroblast growth factor-8 monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1226(2)

Melhem, A.; Alvarez, C.E.; Ilan, Y.; Bishara, A.; Friedman, S.L.; Safadi, R. 2003: Anti-fibrotic activity of NK cells in experimental liver injury through enhanced activation combined with increased susceptibility of activated HSCs to killing. Hepatology 38(4 Suppl 1): 233A

Geesin, J.C.; Gosiewska, A. 2004: Anti-fibrotic agent assay. Official Gazette of the United States Patent and Trademark Office Patents 1283(3)

Moal, F.; Vuillemin, E.; Wang, J.; Veal, N.; Oberti, F.; Gallois, Y.; Barriere, E.; Rousselot, D.; Cales, P. 2001: Anti-fibrotic effects of a new liver specific no donor in bile duct ligated rats. Journal of Hepatology 34(Suppl 1): 5-6

Geerts, A.E.manuel Corneille; Niki, T. 1999: Anti-fibrotic medicament. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Harris, J.W. 2000: Anti-first-pass effect compounds. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)

Harris, J.W. 1999: Anti-first-pass effect compounds and citrus extract. Official Gazette of the United States Patent and Trademark Office Patents 1228(4)

Heerze, L.D.; Armstrong, G.D.; Smith, R. 2001: Anti-flammatory carbohydrate binding-peptides. Official Gazette of the United States Patent and Trademark Office Patents 1247(2)

Wisnewski, N.; Silver, G.M.; Lo, K.C.; Brandt, K.S. 2001: Anti-flea epoxide hydrolase antibodies and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1250(3)

Yamey 1999: Anti-flu drug may not reduce death rate. BMJ 319(7211): 659

Bonaventura, C.; Bonaventura, J.; Hooper, I.R. 1999: Anti-fouling methods using enzyme coatings. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Oppenheim, F.G.; Xu, T.; Roberts, F.D.; Spacciapoli, P.; Friden, P.M. 1999: Anti-fungal D-amino acid histatin-based peptides. Official Gazette of the United States Patent and Trademark Office Patents 1220(4): 3551

Peethambaran,B.; Hawkins,L.; Windham,G.L.; Williams,W.P.; Luthe,D.S. 2010: Anti-fungal activity of maize silk proteins and role of chitinases in Aspergillus flavus resistance. Toxin Reviews: 1, 27-39

Garofano, D. 2002: Anti-fungal composition. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)

Shahi, S.K.; Shukla, A.C.; Dikshit, A.; Bajaj, A.K.; Singh, A.K.; Kumar, S. 2001: Anti-fungal formulation active against a broad spectrum of dermatophytoses. Official Gazette of the United States Patent and Trademark Office Patents 1252(1)

Bindra, R.L.; Singh, A.K.; Shawl, A.S.; Kumar, S. 2001: Anti-fungal herbal formulation for treatment of human nails fungus and process thereof. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)

Little, R.G.I.L.m, E.; Fadem, M.B. 1999: Anti-fungal peptides. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1330

Flood, M.G.; Hamilton, R.M. 2004: Anti-g pressure regulator for supplying breathable gas to a pilots face mask and method. Official Gazette of the United States Patent and Trademark Office Patents 1287(3)

Kokko, K.E.; Wagener, M.E.; Dai, Z.; Lakkis, F.G. 2001: Anti-gammac but not anti-CD25 antibodies suppress allospecific CD8+ T cell memory and facilitate cardiac allograft acceptance in mice. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 860A

Carpo, M.; Bersano, A.; Citterio, A.; Allaria, S.; Cosi, V.; Nappi, G.; Scarlato, G.; Nobile Orazio, E. 2000: Anti-ganglioside and anti-Campylobacter jejuni antibodies in Guillain-Barre syndrome A case-control study. Neurology 54(7 Supp 3): A135

Labrador, M.; Gallardo, E.; Serrano, C.; Illa, I.; Ordi, J.; Vilardell, M. 2001: Anti-ganglioside antibodies by ELISA and TLC methods in patients with SLE. Lupus 10(Suppl 1): S34

Willison, H.J. 2000: Anti-ganglioside antibodies in autoimmune neuropathies. European Journal of Neurology 7(Suppl 3): 166

Crescibene, L.; Bastone, L.; Bagala, A.; Napoli, I.D.; Ferraro, T. 2002: Anti-ganglioside antibodies in epileptic patients. Lupus 11(9): 556

Prendergast, M.M.; Moran, A.P. 2001: Anti-ganglioside antibodies induced by ganglioside-mimicking Campylobacter jejuni lipopolysaccharide bind to epitopes at the nodes of Ranvier. IJMM International Journal of Medical Microbiology 291(Suppl 31): 125

Islam, M.W.; Zakaria, M.N.M.; Radhakrishnan, R.; Liu, X.M.; Chan, K.; Al Attas, A. 2000: Anti-gastric ulcer and cytoprotective properties of Aarak tree and Purslane in rats. Journal of Pharmacy and Pharmacology 52(Suppl): 269

Shi, C.; Parker, A.R.; Hua, L.; Morrell, C.; Eshleman, J.R. 2003: Anti-gene padlocks of various lengths selectively kill bacterial cells with chromosome targets. Proceedings of the American Association for Cancer Research 44: 345

Xodo, L.E.; Cogoi, S.; Rapozzi, V. 2004: Anti-gene strategies to down-regulate gene expression in mammalian cells. Current Pharmaceutical Design 10(7): 805-819

Kaya, B. 2003: Anti-genotoxic effect of ascorbic acid on mutagenic dose of three alkylating agents. Turkish Journal of Biology 27(4): 241-246

Ansari, S.A.; Polefka, T.G. 2001: Anti-germ attachment--composition. Official Gazette of the United States Patent and Trademark Office Patents 1242(5)

Carrillo, D.Albornoz, Antonio Osuna 2004: Anti-gliadin MAb. Hybridoma and Hybridomics 23(1): 85-86

Uibo, O.; Sullivan, E.; Lernmark, A.; Salur, L.; Mandel, M.; Uibo, R. 2000: Anti-gliadin and GAD65 antibodies in a random adult population sample. FASEB Journal 14(6): A1236

Tsakona, C.P.; Bracewell, J.; Sneade, K.A.; Pumphrey, R.S.H. 1999: Anti-gliadin antibodies do not contribute useful information in diagnosing gluten induced enteropathy. Immunology 98(Suppl 1): 159

Uibo, O.; Salur, L.; Talvik, I.; Metskula, K.; Talvik, T.; Uibo, R. 1999: Anti-gliadin antibodies in children with neurological dysfunction. Immunology Letters 69(1): 103

Burlakov, S.D.; Genkin, D.D.; Surkov, K.G.; Tets, V.V. 1999: Anti-glucocorticoid drug. Official Gazette of the United States Patent and Trademark Office Patents 1227(2)

Pedersen, S.B.; Kristensen, K.; Richelsen, B. 2003: Anti-glucocorticoid effects of progesterone on rat adipose tissue metabolism in vivo. International Journal of Obesity 27(Suppl 1): S60

Levite, M.; Ganor, Y.; Goldberg, H.; Pelled, D.; Futerman, A.H.; Eshhar, Z. 2001: Anti-glutamate receptor antibodies from human epileptic patients and rats immunized with receptor-derived peptides, cause excitotoxic neuronal death. FASEB Journal 15(5): A1066

Krupitsky, E.M.; Rudenko, A.A.; Burakov, A.M.; Zvartau, E.E.; Slavina, T.Y.; Grinenko, A.Y.; Krystal, J.H. 2003: Anti-glutamate treatments for alcohol detoxification A double-blind placebo-controlled pilot study of lamotrigine and memantine. Alcoholism Clinical and Experimental Research 27(5 Suppl): 149A

Haroun, M. 2000: Anti-goat immunoglobulin antibodies in adult diabetic patients. Hormone Research 53(Suppl 2): 138

Horwitz, A.; Lambert, L.H.; Little, R.G. 2000: Anti-gram-positive bacterial methods and materials. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)

Hallin, P.; Madden, T.; Fan, Z.; Mendelsohn, J.; Chiao, P. 1999: Anti-growth factor receptor monoclonal antibodies enhance the activity of 5-FU in human pancreatic cancer cell lines. Proceedings of the American Association for Cancer Research 40: 400

Conde, Ileana Baluja 2000: Anti-hTSH 2C1-G10 and 4A2-A8. Hybridoma 19(4): 353

Affleck, L.; Dodd, I.; Smith, G.P.; Smith, R.A.G. 1999: Anti-haemolytic activity and flow cytometric cell-binding analysis of APT070 - A novel membrane-targeted complement inhibitor. Molecular Immunology 36(4-5): 309

Kang, P.C.; Suzuki, D.A.; Yee, R.D. 2000: Anti-head/eye gaze saccades in humans. IOVS Investigative Ophthalmology and Visual Science 41(4): S308

Bene, L.; Miklos, K.; Kovacs, A.; Hernadi, Z.S.; Fekete, B.; Fust, G. 2000: Anti-heat shock protein 65 antibody in inflammatory bowel disease. Immunology Letters 73(2-3): 141

Komiya, I.; Arimura, Y.; Yamada, A.; Osaki, T.; Yamaguchi, Y.; Kamiya, S. 2003: Anti-heat shock protein antibody in patients with MPO-ANCA associated vasculitis. Kidney and Blood Pressure Research 26(4): 273

Watanabe, M.; Tanaka, K.; Komiya, M.; Rantiatmodjo, R.M.rni 2001: Anti-helicobacter pylori pharmaceutical composition. Official Gazette of the United States Patent and Trademark Office Patents 1243(1)

Paparella, D.; Micelli, M.; Favoino, B.; D'Alò, M.; Fiore, T.; de Luca Tupputi Schinosa, L. 2001: Anti-heparin-platelet factor 4 antibodies after cardiopulmonary bypass: role of HLA expression. Haematologica 86(3): 326-327

Nakamura, S.; Nouso, K.; Araki, Y.; Ikeda, H.; Takaguchi, K.; Fujio, K.; Seno, T.; Ando, M.; Kiyono, S.; Kawaguchi, M.; Itoshima, T.; Ukida, M.; Shimamura, J.; Inoue, J.I.; 2002: Anti-hepatitis B e antigen is prevalent in patients with hepatitis B virus-related hepatocellular carcinoma in Japan. Hepatology 36(4 Part 2): 699A

Bryant, M.L.; Gosselin, G.; Schinazi, R.F.; Imbach, J.L.; Sommadossi, J.P. 2000: Anti-hepatitis B specific beta-L-2-deoxynucleosides. Antiviral Research 46(1): A55

Gish, R.G.; Leung, N.W.Y.; Wright, T.L.; Trinh, H.; Robertson, A.T.; Harris, J.J.; Delehanty, J.T.; Rousseau, F.S. 1999: Anti-hepatitis B virus activity and pharmacokinetics of FTC in a 2-month trial in HBV-infected patients. Gastroenterology 116(4 Part 2): A1216

Gilani, A.H.; Janbaz, K.H.; Saeed, S.A. 1999: Anti-hepatotoxic activity of caffeic acid A phenolic compound from Artemisia scoparia. Biochemical Society Transactions 27(5): A145

Kuwada, S.K.; Li, X.; Scaife, C.L. 1999: Anti-her-2 growth factor receptor antibody inhibits cell proliferation and anchorage-independent growth in colon cancer cell lines. Gastroenterology 116(4 Part 2): A446-A447

Rousseau, J.; Ribbens, E.; Alton, T.H. 2003: Anti-herbivore and antibacterial properties of Guaiacum sanctum. Transactions of the Illinois State Academy of Science 96(Suppl): 32

Cardin, A.D.; Jackson, R.L.; Mullins, M.J. 2001: Anti-herpes virus and cytomegalovirus polyurea oligomers. Official Gazette of the United States Patent and Trademark Office Patents 1246(3)

Marsden, H.S.; Stow, N.D.; Mclean, G.W. 2002: Anti-herpesviral agent. Official Gazette of the United States Patent and Trademark Office Patents 1254(2)

Mclauchlan, J.; Mcgeoch, D.J.; Hope, R.G.; Rixon, H.W. Mclaren 2001: Anti-herpesviral agents and assays therefor. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Crute, J.J.; Faucher, A.M.; Grygon, C.A.; Hargrave, K.D.; Simoneau, B.; Thavonekham, B. 2000: Anti-herpesvirus compounds and methods for identifying, making and using same. Official Gazette of the United States Patent and Trademark Office Patents 1234(1)

Alves, J.D.; Ames, P.R.J.; Donohue, S.; Noorouz Zadeh, J.; Ravirajan, C.T.; Isenberg, D.A. 2002: Anti-high density lipoprotein and anti-B2GPI antibodies inversely correlate with paraoxonase activity and total antioxidant capacity in patients with SLE and APS. Lupus 11(9): 586

Molinari, A.; Gerna, M.; Giorgetti, C.; Lansen, J.; Roncucci, R. 2004: Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Yudate, T.; Ashenager, M.; Aragane, Y. 2004: Anti-histamines Implication as immune modulators. Journal of Investigative Dermatology 123(2)

Pei, J.; Barsoukov, A.; Lin, M.T.; Frangoul, H.; Petersdorf, E.W.; Hansen, J.A. 1999: Anti-host interleukin-2 secreting CD4+ T cell responses after allogeneic hematopoietic cell transplantation. Human Immunology 60(Suppl 2): S107

Zhang, Xue Guang 2003: Anti-human 4-1BB ligand monoclonal antibody or anti-human CD137 ligand monoclonal antibody. Hybridoma and Hybridomics 22(6): 407

Krance, R.; Rill, D.; Khan, S.; Kuehnle, I.; Heslop, H.E.; Przepiorka, D.; Carrum, G.; Popat, U.; Brenner, M.K. 2001: Anti-human CD45 antibody therapy preceding allogeneic stem cell transplantation for high risk hematologic malignancies. Blood 98(11 Part 1): 777a-778a

Arai, T. 2001: Anti-human LECT2 antibody, cells producing the same, and method and kit for assaying the same. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)

Stahl, G.L. 2002: Anti-human MBL, 3F8, 2A9. Hybridoma and Hybridomics 21(3): 224

Kitagawa, H.; Jitsukawa, T.; Nakagawa, H.; Yanagisawa, S. 2001: Anti-human MP52 monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1253(2)

Yamaguchi, K.; Yonemura, Y.; Okabe, H.; Takahama, Y.; Nagai, S.; Yamaguchi, H.; Hirai, K. 2003: Anti-human T-lymphotropic virus type-I antibody detection by a novel counting immunoassay which can measure whole blood. AIDS Research and Human Retroviruses 19(Suppl): S-51-S-52

Shitara, K.; Ito, M.; Hanai, N. 2003: Anti-human VEGF receptor Flt-1 monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1274(2)

Jonak, Z.L.; Taylor, A.; Trulli, S.H.; Johanson, K.O. 2000: Anti-human alphav beta3 and alphav beta5 antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)

Nishiyama, U.; Tanaka, S.; Kuwaki, T.; Kato, T.; Miyazaki, H. 2003: Anti-human c-Mpl monoclonal antibodies including an agonistic clone. Experimental Hematology (New York) 31(7 Suppl 1): 162-163

Yamashita, N.; Nakamoto, M.; Miura, K.; Kataoka, C.; Sakaki, J. 2000: Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)

Hiyamuta, S.; Shimizu, K.; Kadota, A. 2000: Anti-human ceruloplasmin monoclonal antibody. Official Gazette of the United States Patent and Trademark Office Patents 1230(1)

D'agostini, M.; Briere, F. 2000: Anti-human dendritic cell monoclonal antibodies. Tissue Antigens 55(Suppl 1): 55

Izumi, Y.; Fukumura, D.; Jain, R.K. 2002: Anti-human epidermal growth factor receptor 2 antibody Herceptin is anti-angiogenic in HER2 overexpressing breast cancer. Proceedings of the American Association for Cancer Research 43: 658

Mukhtar, M.; Duke, H.; BouHamdan, M.; Pomerantz, R.J. 2000: Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir. Human Gene Therapy 11(2): 347-359

Okuno, Y.; Isegawa, Y.; Sasao, F.; Ueda, S. 2004: Anti-human influenza virus antibody. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Skurkovich, S.; Kasparov, A.; Narbut, N.; Skurkovich, B. 2001: Anti-human interferon-gamma antibodies in the treatment of patients with corneal transplant rejection. Journal of Leukocyte Biology Suppl: 87

Aoki, Y.; Suzuki, H.; Takahashi, K.; Katsuragi, H. 2004: Anti-human medullasin monoclonal antibody process for producing the same and immunoassay using the same. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)

Soe, G.; Kohno, I.; Shiiba, M. 1999: Anti-human plasmin-alpha-2-plasmin inhibitor complex antibodies, hybridomas, and immunological determination method. Official Gazette of the United States Patent and Trademark Office Patents 1220(5): 4516

Tsuganezawa, K.; Karasuyama, H. 2002: Anti-human pre-B cell receptor antibody. Official Gazette of the United States Patent and Trademark Office Patents 1254(1)

Brunden, K.; Bansal, R.; Bokesch, P.M.; Parent, J.B. 1999: Anti-human properdin MoAbs block activation of the alternative pathway in vitro and in ex vivo models of CPB. Molecular Immunology 36(4-5): 310

Bokesch, P.; Bansal, R.; Parent, J.B.; Brunden, K. 1999: Anti-human properdin monoclonal antibodies block activation of the alternative pathway in a model of cardiopulmonary bypass. Anesthesiology 91(3A): A717

Lecerf, J.M.; Shirley, T.L.; Zhu, Q.; Huston, J.S.; Messer, A. 1999: Anti-huntingtin single-chain Fv intrabody retargets co-transfected HD protein. Society for Neuroscience Abstracts 25(1-2): 830

Clayton, N.M.; Collins, S.D.; Pass, M.; Chessell, I.P.; Bountra, C. 2003: Anti-hyperalgesic and anti-inflammatory activity of a potent and selective adenosine A1 receptor agonist 5-deoxy-5-fluoro-N- -adenosine. British Journal of Pharmacology 138(Proceedings Suppl): 28P

Bianchi, M.; Limiroli, E.; Ferrario, P.; Sacerdote, P. 2001: Anti-hyperalgesic effects of lornoxicam in the rat Behavioural and biochemical evidence. Inflammation Research 50(Suppl 3): S207

Bianchi, M.; Panerai, A.E. 2001: Anti-hyperalgesic effects of lornoxicam, piroxicam, meloxicam, ketorolac, and aspirin in rats. British Journal of Pharmacology 133(Proceedings Suppl): 51P

Bowes, M.; Panesar, M.; Gentry, C.; Urban, L.; Gasparini, F.; Kuhn, R.; Walker, K. 1999: Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6- -pyridine, in rat models of inflammatory pain. British Journal of Pharmacology 126(Proceedings Suppl ): 250P

Cheng, K.; Wright, S.D.; Wu, T.J. 2004: Anti-hypercholesterolemic drug combination. Official Gazette of the United States Patent and Trademark Office Patents 1278(3)

Doo, H.K.; Shim, Y.J.; Kim, E.H.; Ahn, S.Y.; Kim, Y.S.; Seong, J.K.; Min, B.H.; Park, I.S. 2003: Anti-hyperglycemic activity of aqueous extract from the gall of Rhus chinensis and its protective effect on beta-cell injury. Diabetes 52(Suppl 1): A549

Deguchi, Y.; Miyazaki, K. 2010: Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutrition and Metabolism 7: 9

Andallu, B.; Varadacharyulu, N.C. 2002: Anti-hyperglycemic and anti-oxidant role of mulberry leaves. Indian Journal of Pharmacology 34(2): 145

WangTzuChing; LinChunChing; LeeHouI.Y.ng,C.; YangChiChing 2010: Anti-hyperlipidemic activity of spider brake with rats fed a high cholesterol diet. Pharmaceutical Biology: 2, 221-226

Kwak, Y-Seong.; Kyung, J-Soo.; Kim, J.Soo.; Cho, J.Youl.; Rhee, M-Hee. 2010: Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biological and Pharmaceutical Bulletin 33(3): 468-472

Blann, A.; Nadar, S.; Lip, G. 2004: Anti-hypertension treatment reduces platelet derived VEGF and angiopoietin-1 in hypertension. British Journal of Haematology 125(Suppl 1): 51

Vollenweider, P. 2003: Anti-hypertensive and natriuretic effect of glucagon-like peptide 1 in Dahl S rats: a novel function for a pleotrophic hormone?. Journal of Hypertension 21(6): 1079-1080

Albertini, M.C.; Piatti, E.; Uguccioni, F.; Rocchi, M.B.L.; Baldoni, F.; Accorsi, A. 2003: Anti-hypertensive calcium channel antagonist drugs Preliminary studies on erythrocytes from normal subjects and therapy candidates. European Journal of Histochemistry 47(3): 268

Kato, T.; Hayashi, I.; Suzuki, M.; Majima, M. 2002: Anti-hypertensive effect of ATP-sensitive potassium channel blocker via enhanced secretion of renal kallikrein in rat. Japanese Journal of Pharmacology 88(Suppl 1): 206P

Home, P.; Piaditis, G.; Koelendorf, K.; Raz, I.; Murphy, L.; Smith, P.; Kler, L.; Dave, J.; Tandy, D. 2001: Anti-hypertensive effect of farglitazar, a PPARgamma agonist, in patients with type 2 diabetes and hypertension. Diabetologia 44(Suppl 1): A274

Home, P.D.; Piaditis, G.; Koelendorf, K.; Raz, I.; Murphy, L.; Smith, P.L.; Kler, L.; Dave, J.; Tandy, D. 2001: Anti-hypertensive effect of farglitazar, a tyrosine-based non-thiazolidinedione PPARgamma agonist, in patients with type 2 diabetes and hypertension. Diabetes 50(Suppl 2): A117

Smits, J.F.; Auton, T.R.; Sharp, H.L.; Downham, M.R.; Glover, J.F.; Janssen, B.J. 1999: Anti-hypertensive properties of angiotensin immuno-therapeutic in spontaneous hypertension in rats. FASEB Journal 13(4 Part 1): A483

Roman, M.J.; Fishman, D.P.; Lee, E.T.; Marion, S.; Fabsitz, R.R. 1999: Anti-hypertensive therapy may not reverse arterial hypertrophy The strong heart study. Circulation 100(18): 1; 176

Birebent, B.; Purev, E.; Li, W.; Akis, N.; Staib, L.; Somasundaram, R.; Andl, C.; Mitchell, E.; Nair, S.; Herlyn, D. 1999: Anti-idiotype and recombinant antigen vaccines. Proceedings of the American Association for Cancer Research 40: 338-339

Eivazova, E.R.; Mcdonnell, J.M.; Sutton, B.J.; Staines, N.A. 1999: Anti-idiotype antibodies with dual specificity for DNA and their potential pathogenicity in SLE. Arthritis and Rheumatism 42(9 Suppl): S53

Foon, K.A.; Bhattacharya Chatterjee, M. 2000: Anti-idiotype antibody vaccines for colon cancer, breast cancer and malignant melanoma. Journal of Immunotherapy 23(5): 588

Becker, Maria Ines 2004: Anti-idiotype gizzerosine 3A12. Hybridoma and Hybridomics 23(2): 148-149

Howell, M.D.; Brostoff, S.W.; Carlo, D.J. 1999: Anti-idiotype vaccination against diseases resulting from pathogenic responses by specific T cell populations. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

Reece, D.; Foon, K.A.; Chatterjee, M.; Connaghan, G.; Holland, K.; Munn, R.; Dipersio, J.; Simpson, D.; Teitelbaum, A.; Phillips, G. 1999: Anti-idiotype vaccination plus intensive therapy and autologous stem cell transplantation for patients with metastatic breast cancer. European Journal of Cancer 35(Suppl 4): S353

Wikstrand, C.J.; Cole, V.R.; Bigner, D.D. 2000: Anti-idiotype vaccine approach to EGFRvIII-expressing tumors. Proceedings of the American Association for Cancer Research 41: 880

McCarthy, H.; Ottensmeier, C.H.; Hamblin, T.J.; Stevenson, F.K. 2003: Anti-idiotype vaccines. British Journal of Haematology 123(5): 770-781

Raso, V.; Paulus, H. 2000: Anti-idiotype vaccines to elicit catalytic antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)

Hollander, N.; Cohen, S.; Haimovich, J. 2002: Anti-idiotype Xanti-LFA-1 bispecific antibodies inhibit liver metastasis of B-cell lymphoma. FASEB Journal 16(4): A663-A664

Wagner, U. 1999: Anti-idiotypes for breast and ovarian cancer. European Journal of Cancer 35(Suppl 5): S49

Hacker, M.K.; Olasz, E.B.; Fairley, J.A.; Yancey, K.B.; Lin, M. 2003: Anti-idiotypic IgG blocks the reactivity and pathogenicity of anti-desmoglein-3 autoantibodies from patients with pemphigus vulgaris. Journal of Investigative Dermatology 121(1): 0080

Muller, S.; Wang, H. 2001: Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Ho, M.; Segre, M. 2002: Anti-idiotypic antibodies mimic cocaine and bind the dopamine transporter Their binding properties, structures and molecular modeling. FASEB Journal 16(4): A722-A723

Carceller, A.; Rosell, E.; Gomez, A.; Adan, J.; Piulats, J. 1999: Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)

Wu, Xue Ru 2003: Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same. Official Gazette of the United States Patent and Trademark Office Patents 1275(2)

Muller, S.; Wang, H. 2002: Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease. Official Gazette of the United States Patent and Trademark Office Patents 1263(3)

Birebent, B.; Somasundaram, R.; Purev, E.; Li, W.; Mitchell, E.; Hoey, D.; Bloom, E.; Mastrangelo, M.; Maguire, H.; Harris, D.T.; Staib, L.; Braumuller, H.; Leeser, C.; Kuttner, N.; Beger, H.G.; Herlyn, D. 2001: Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients. Critical Reviews in Oncology/Hematology 39(1-2): 107-113

Baldwin, R.W.; Durrant, L.G.; Austin, E.B.; Byers, V.S. 2000: Anti-idiotypic antibody induction of anti-tumor response. Official Gazette of the United States Patent and Trademark Office Patents 1232(4)

Chapman, P.B.; Houghton, A.N. 2002: Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1261(2)

Friboulet, A.; Thomas, D. 1999: Anti-idiotypic catalytic antibodies. Journal of Autoimmunity (Suppl ): 46

Krause, I.; Blank, M.; Levi, Y.; Koike, T.; Barak, V.; Shoenfeld, Y. 1999: Anti-idiotypic immunomodulation of experimental anti-phospholipid syndrome via reversal of Th1/Th2 expression. Journal of Autoimmunity (Suppl ): 18

Vazguez Lopez, A.M.; Rodriguez, R.P.; Guerra, E.I.; Perez, A.; Lopez, G.B.; Delgado, I.B. 2000: Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1234(3)

Vazguez Lopez, A.M.; Perez Rodriguez, R.; Guerra, E.I.; Perez, A.; Lopez, G.B.; Delgado, I.B. 2002: Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions including the anti-idiotypic monoclonal antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)

Routsias, J.G.; Touloupi, E.; Sakarellos Daitsiotis, M.; Dotsika, H.; Sakarellos, C.; Moutsopoulos, H.M.; Tzioufas, A.G. 2001: Anti-idiotypic response targets a common idiotype on anti-La/SSB autoantibodies in patients with Sjogrens Syndrome and Systemic Lupus Erythematosus. Lupus 10(Suppl 1): S52

Johnson, D.L.; Hendrickson, W.A. 2000: Anti-immunoresponsive polymeric material and its use in biological applications. Official Gazette of the United States Patent and Trademark Office Patents 1235(1)

Masini, M.A. 2002: Anti-impingement hip system. Official Gazette of the United States Patent and Trademark Office Patents 1258(1)

Sultan, H. 2000: Anti-incontinence device. Official Gazette of the United States Patent and Trademark Office Patents 1239(4)

Giebel, M.; Boemke, W.; Palm, U. 2000: Anti-infection catheter. Official Gazette of the United States Patent and Trademark Office Patents 1240(2)

Dent, James, L.Jr 2003: Anti-infection formulation and delivery method. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)

Kolodziej, H.; Heger, M. 2000: Anti-infectious principles and clinical efficacy of Pelargonium species in respiratory tract infections. Phytomedicine 7(Suppl 2): 83

Ghisalberti, E.L. 2002: Anti-infective agents produced by the hyphomycetes genera Trichoderma and Gliocladium. Current Medicinal Chemistry - Anti-Infective Agents 1(4): 343-374

Solomon, D.D.; Byron, M.P.rke 2001: Anti-infective and antithrombogenic medical articles and method for their preparation. Official Gazette of the United States Patent and Trademark Office Patents 1248(3)

Rosenberg, M.; Johnston, S.L. 2001: Anti-infective challenges in the 21st century From superbugs to viral pandemics. Current Opinion in Pharmacology 1(5): 449-450

Johnson, B.Ron 2002: Anti-infective compositions for treating disordered tissue such as cold sores. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)

Johnson, B.Ron 2004: Anti-infective compositions, methods and systems for treating disordered tissue. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)

Whitbourne, R.J.; Zhang, X. 2002: Anti-infective covering for percutaneous and vascular access device and coating method. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)

Thorlacius, H.; Jeppsson, B. 2003: Anti-infective effects of lactobacilli in the gastrointestinal tract. Current Medicinal Chemistry - Anti-Infective Agents 2(4): 263-267

Darouiche, R.O. 1999: Anti-infective efficacy of silver-coated medical prostheses. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 29(6): 1371-1377; Quiz 1378

Kirschner, U.; Jethon, F.; Rauch, F. 1999: Anti-infective material. Official Gazette of the United States Patent and Trademark Office Patents 1225(4)

Kontinen, V.K. 2001: Anti-infectives New technologies Web alert. Current Opinion in Pharmacology 1(5): 447-448

Phipps, R.P.; Ray, D. 2002: Anti-inflammatory 15d-PGJ2 and PPARgamma agonists induce apoptosis in B lineage cells by a caspase and NFkappaB-dependent mechanism Implications for immunity. FASEB Journal 16(5): A1049

Juan, S C.; Lichenstein, H.S.; Wright, S.D. 1999: Anti-inflammatory CD14 polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1471

Breborowicz, A.; Kuzlan Pawlaczyk, M.; Pawlaczyk, K.; Moberly, J.; Martis, L.; Oreopoulos, D. 2002: Anti-inflammatory action of Hyaluronan during peritoneal dialysis. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 41-42

Chew, B.P.; Park, H.J.; Park, J.S.; Wong, T.S.; Kim, H.W.; Hayek, M.G.; Reinhart, G.A. 2001: Anti-inflammatory action of dietary fish and flaxseed oils in cats. FASEB Journal 15(4): A294

Woo, M.G.; Geiger, J.D. 2003: Anti-inflammatory actions of adenosine are mediated in part by matrix metalloproteinase inhibition. FASEB Journal 17(4-5): Abstract 152

Node, K.; Liao, J.K. 1999: Anti-inflammatory actions of epoxygenase-derived eicosanoids. Journal of the American College of Cardiology 33(2 Suppl A): 2A

LeeJeongSang; PaekNamSoo; KwonOhSang; HahmKiBaik 2010: Anti-inflammatory actions of probiotics through activating suppressor of cytokine signaling expression and signaling in Helicobacter pylori infection a novel mechanism. Journal Of Gastroenterology And Hepatology: 1, 202

Krady, J.K.; Basu, A.; Enterline, J.R.; Levison, S.W. 2002: Anti-inflammatory actions of transforming growth factor-beta1 on rat microglia. Journal of Neurochemistry 81(Suppl 1): 52

Hanania, N.A.; Moore, R.H. 2004: Anti-inflammatory activities of beta2-agonists. Current Drug Targets. Inflammation and Allergy 3(3): 271-277

Jun, M.; Hong, J.; Yang, C.S.; Ho, C.T.ng 2003: Anti-inflammatory activities of isoflavones from kudzu root. Abstracts of Papers American Chemical Society 226(1-2): AGFD 40

Kontny, E.; Maśliński, W.ło.; Marcinkiewicz, J. 2003: Anti-inflammatory activities of taurine chloramine: implication for immunoregulation and pathogenesis of rheumatoid arthritis. Advances in Experimental Medicine and Biology 526: 329-340

Petersen, T.K.; Aaes, H.; Skak Nielsen, T.; Ottosen, E.R.; Bramm, E. 2004: Anti-inflammatory activities of the p38 MAP kinase inhibitor EO1606 in dermatological disease models. Journal of Investigative Dermatology 123(2)

Mahmoudi, M.; Morteza Semnani, K.; Saeedi, M.; Javanmardi, A. 2003: Anti-inflammatory activity and acute toxicity of Iranian Hypericum perforatum. Toxicology Letters (Shannon) 144(Suppl 1): s89

Dorsch, W.; Suttorp, N.; Lottspeich, F.; Zepp, F. 1999: Anti-inflammatory activity in human skin: it prevents edema formation in vitro. International Archives of Allergy and Immunology 118(2-4): 236-239

Jeenapongsa, R.; Yoovathaworn, K.; Sriwatanakul, K.M.; Pongprayoon, U.; Sriwatanakul, K. 2003: Anti-inflammatory activity of -1- butadiene from Zingiber cassumunar Roxb. Journal of Ethnopharmacology 87(2-3): 143-148

Koc,F.; Cadirci,E.; Albayrak,A.; Halici,Z.; Hacimuftuoglu,A.; Suleyman,H. 2010: Anti-inflammatory activity of 2,5-dihydroxycyclohepta-2,4,6-trienone in rats. Medicinal Chemistry Research: 1, 84-93

Lee, Eun Bang 2001: Anti-inflammatory activity of Americanin A with its physiological aspect. Mori, Akitane, Satoh, Tetsuo Emerging Drugs Molecular aspects of Asian medicine 203-213

Simirgiotis, M.; Favier, S.; Cifuente, D.; Rotelli, A.; Juarez, A.; Pelzer, L. 2000: Anti-inflammatory activity of Baccharis medulosa DC, Baccharis rufenscens S and Conyza sophiaefolia extracts in mice. Biocell 24(3): 304

Stuppner, H.; Dobner, M.J.; Sosa, S.; Della Loggia, R.; Dunzendorfer, S.; Wiedermann, C.J. 2000: Anti-inflammatory activity of Leontopodium alpinum. Phytomedicine 7(Suppl 2): 97

Martin, M.; Serradji, N.; Clayette, P.; Bosquet, N.; Heymans, F.; Dormont, D. 2000: Anti-inflammatory activity of a PAF-R antagonist Role in HIV replication in MDM. Journal of Neurovirology 6(3): 262

Rogerio, A.P.; Nunes, A.S.; Albuquerque, D.A.; Anibal, F.F.; Prado, J.C.Jr; Faccioli, L.H. 2001: Anti-inflammatory activity of an aqueous extract of Lafoensia pacari in murine toxocariasis. Inflammation Research 50(Suppl 3): S182

Ismail, H.; Kerkeni, E.; Kacem, Y.; Chehab, O.; Mehdouani, K.; Biard, J.F.; Bouraoui, A. 2003: Anti-inflammatory activity of aqueous extracts from mediterranean marine invertebrates. Inflammation Research 52(Suppl 2): S 120

Shin, E.M.; Zhou, H.Y.; Xu, G.H.; Lee, S.H.; Merfort, I.; Kim, Y.S. 2010: Anti-inflammatory activity of hispidol a 25-methyl ether, a triterpenoid isolated from Ponciri Immaturus Fructus. European Journal of Pharmacology 627(1-3): 318-324

Marzocco, S.; Serraino, I.; Cuzzocrea, S.; Sorrentino, R.; Pinto, A.; Autore, G. 2004: Anti-inflammatory activity of methylguanidine on carrageenan induced rat pleurisy. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R170

Battu, G.R.; Zeitlin, I.J.; Gray, A.I. 2000: Anti-inflammatory activity of myeloperoxidase inhibitory molecules isolated from resin extracts of Commiphora kua. British Journal of Pharmacology 131(Proceedings Suppl December): 187P

Baltabaev, U.A.; Makhsumov, A.G.; Zakirov, U.B.; Babaev, I.D.; Shukurullaev, K. 2002: Anti-inflammatory activity of new aryl- and aroylthioureas. Khimiko-Farmatsevticheskii Zhurnal 36(2): 24-26

Alvarez, M.E.; Saad, J.R.; Giordano, O.S.; Rotelli, A.; Pelzer, L. 2000: Anti-inflammatory activity of principles isolated from Lampaya hieronymi. Biocell 24(3): 304

Al-Reza, S.M.; Yoon, J.I.; Kim, H.J.; Kim, J.-S.; Kang, S.C. 2010: Anti-inflammatory activity of seed essential oil from Zizyphus jujuba. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48(2): 639-643

Maragkoudakis, P.; Petraki, K.; Martinez, B.; Michopoulos, S.; Kalantzopoulos, G.; Pot, B.; Tsakalidou, E.; Mentis, A.; Sgouras, D.N. 2003: Anti-inflammatory activity of the probiotic Lactobacillus casei strain Shirota in C57BL6 mice infected with Helicobacter pylori SS1 strain. Helicobacter 8(4): 412

Bhol, K.C.; Alroy, J.; Schechter, P.J. 2003: Anti-inflammatory activity of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Journal of Investigative Dermatology 121(1): 1187

Battu, G.R.; Zeitlin, I.J.; Gray, A.I. 2001: Anti-inflammatory activity on adjuvant-induced arthritis in rats of octanordammarane triterpenes from resin extracts of Commiphora kua. British Journal of Pharmacology 133(Proceedings Suppl): 199P

Van Der Flier, M.; Geelen, S.P.M.; Kimpen, J.L.L. 2002: Anti-inflammatory adjuvant agents in bacterial meningitis. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents 1(1): 55-62

Kyogashima, M.; Asari, A. 2003: Anti-inflammatory agent. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)

Garbati, M.; Maddock, D.; Chiu, C.; Lai, D.; Yang, D.; Hu, G.; Wan, Y. 2002: Anti-inflammatory agent in extracts from Epimedium grandiflorum morr inhibits IL-1beta-induced expression of IL-6 via inhibition of IKK activity and phosphorylation of p38 in cultured human keratinocytes. FASEB Journal 16(4): A152

Ayscough, A.P.; Whittaker, M. 2001: Anti-inflammatory agents. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)

Waki, M. 2003: Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1275(1)

Brater, D.C. 2002: Anti-inflammatory agents and renal function. Seminars in Arthritis and Rheumatism 32(3 Suppl 1: 33-42

Niyiro, Y.; Koda, S.; Sugiyama, S. 2002: Anti-inflammatory analgesic. Official Gazette of the United States Patent and Trademark Office Patents 1262(2)

Anikina, L.V.; Vikharev, Y.B.; Safin, V.A.; Gorbunov, A.A.; Shklyaev, Y.V.; Karmanov, V.I. 2002: Anti-inflammatory and analgesic activity of N- -amino acids. Khimiko-Farmatsevticheskii Zhurnal 36(2): 19-23

Afolayan,A.J.; Aboyade,O.M.; Adedapo,A.A.; Sofidiya,M.O. 2010: Anti-inflammatory and analgesic activity of the methanol extract of Malva parviflora Linn in rats. African Journal Of Biotechnology: 8, 1225-1229

Anandhraj, C.; Dhara, A.K.; Saravanan, K.S.; Nagchaudhuri, A.K. 2001: Anti-inflammatory and analgesic activity of the methanolic fraction of the root extract of Trachia - involucrata linn A preliminary study. Indian Journal of Pharmacology 33(4): 303

Ando, K.; Takahashi, K.; Kawakami, M.; Hanatsuka, M. 1999: Anti-inflammatory and analgesic effects of avicatonin on metatarsus damage model in rats. Japanese Journal of Pharmacology 79(Suppl 1): 287P

Barnette, M.S.; Torphy, T.J.; Christensen, S.B.njamin 2000: Anti-inflammatory and anti-asthma treatment with reduced side effects. Official Gazette of the United States Patent and Trademark Office Patents 1240(1)

Rotstein, O.D.; Nathens, A.B. 1999: Anti-inflammatory and anti-pyretic method. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Kundakovic, T.; Dobric, S.; Bokonjic, D.; Dragojevic-Simic, V.; Kilibarda, V.; Kovacevic, N. 2000: Anti-inflammatory and anti-ulcer activity of Achillea alexandri-regis. Die Pharmazie 55(11): 866-867

Karachurina, L.T.; Sapozhnikova, T.A.; Zarudii, F.S.; Flekhter, O.B.; Galin, F.Z. 2002: Anti-inflammatory and anti-ulcer properties of betulin bishemiphthalate. Khimiko-Farmatsevticheskii Zhurnal 36(8): 32-33

Secchi, A.G.; Leonardi, A.; Busato, F.; Fregona, I.A.; Plebani, M. 1999: Anti-inflammatory and antiallergic effect of ketorolac after conjunctival provocation test. IOVS Investigative Ophthalmology and Visual Science 40(4): S684

Brahms, J.C.; Scherl, D.S.; Herles, S.; Shapiro, S.; Gaffar, A. 1999: Anti-inflammatory and antibacterial benzyl phenol agents and their use in oral compositions. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Greenspan, D.C.; West, J.K.; Lee, S.; Meyers, J.L.; Diamond, M. 2004: Anti-inflammatory and antimicrobial uses for bioactive glass compositions. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)

Remirez, D.; Gonzalez, R.; Romay, C.; Ledon, N. 2003: Anti-inflammatory and antioxidant properties of C-phycocyanin. Toxicology Letters (Shannon) 144(Suppl 1): s89

Ckless, K.; Nardi, G.M.; Siqueira, J.M.; Timbola, A.K.; Pizzolati, M.; Ribeiro, D.V., R.M. 2001: Anti-inflammatory and antioxidant properties of ethyl acetate fraction of Croton celtidifolius, in vivo. Free Radical Biology and Medicine 31(10): S44

Klotz, L.; Schmidt, S.; Schmidt, M.; Sastre, M.; Klockgether, T.; Heneka, M.T. 2004: Anti-inflammatory and antiproliferative actions of peroxisome proliferator-activated receptor-gamma agonists on T-lymphocytes in multiple sclerosis patients and healthy controls. Mediators of Inflammation 13(1): 61

Lambiase, A.; Bonini, S.; Aloe, L.; Rama, P.; Bonini, S. 2000: Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Archives of Ophthalmology 118(10): 1446-1449

Yim, Y.-K.; Lee, H.; Hong, K.-E.; Kim, Y.-I.; Ko, S.-K.; Kim, J.-E.; Lee, S.-Y.; Park, K.-S. 2010: Anti-inflammatory and Immune-regulatory Effects of Subcutaneous Perillae Fructus Extract Injections on OVA-induced Asthma in Mice. Evidence-Based Complementary and Alternative Medicine: Ecam 7(1): 79-86

Brock, J.H.; Guillen, C.; Thompson, C. 2000: Anti-inflammatory and immunoregulatory properties of lactoferrin. Shimazaki, Kei-ichi Author, Tsuda, Hiroyuki Author, Tomita, Mamoru Author, Kuwata, Tamotsu Author, Perraudin, Jean-Paul Author International Congress Series; Lactoferrub: Structure, function and applications 119-128

Bannerjee, K.; Croft, N.M.; Camacho Hubner, C.; Babinska, K.; Jivanji, N.; Savage, M.O.; Sanderson, I. 2000: Anti-inflammatory and pro-growth effects precede nutritional changes during enteral feeding in active Crohns disease. JPGN 31(Suppl 2): S274

Dongmo, A.; Salah, M.; Kamanyi, A.; Vierling, W. 2000: Anti-inflammatory and vasodilating properties of the extracts from the stem bark of Mitragyna ciliata. Phytomedicine 7(Suppl 2): 93

Biggadike, K. 2004: Anti-inflammatory androstane derivative. Official Gazette of the United States Patent and Trademark Office Patents 1284(1)

Biggadike, K.; Jones, P.S.; Payne, J.J. 2003: Anti-inflammatory androstane derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1268(4)

Wei, E.T.; Thomas, H.A.; Kishimoto, T. 1999: Anti-inflammatory compositions and method with corticotropin-releasing factor analogs. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1571

Mahe, Y.; Billoni, N.; Breton, L.; Bui Bertrand, L. 2002: Anti-inflammatory compositions comprising peptide derivatives of alpha-MSH/algal extracts. Official Gazette of the United States Patent and Trademark Office Patents 1254(2)

Scott, M.K.; Sanfilippo, P.J.; Fitzpatrick, L.J.I.i; Cordova, R.; Pan, K.; Meschino, J. 2003: Anti-inflammatory compounds. Official Gazette of the United States Patent and Trademark Office Patents 1266(3)

Jacobs, R.S.; Kerr, R.G. 2004: Anti-inflammatory compounds derived from Pseudopterorgorgia elisabethae. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)

Bremner, P.D.; Rivera, D.; Heinrich, M. 2003: Anti-inflammatory compounds from Mediterranean medicinal plants using targets from the nuclear factor-kappa B pathway. South African Journal of Botany 69(2): 226-227

Goulding, N.J. 1999: Anti-inflammatory corticosteroids. Reports on Rheumatic Diseases Series Three Topical Reviews 1999(18): 1-5

Huleihel, M.; Piura, B.; Rabinovich, A.; Wolfson, M.; Holcberg, G.; Mazor, M. 1999: Anti-inflammatory cytokine antibodies are differently affect MMP-9 secretion by SKOV-3 cells. Cytokine 11(11): 913

Yang, S.Y.; Song, Z.; Robbins, P.D.; Evans, C.H.; Wu, B.; Mayton, L.; Nasser, S.; Wooley, P.H. 1999: Anti-inflammatory cytokine gene therapy in a murine model of aseptic loosening. Arthritis and Rheumatism 42(9 Suppl): S284

Engel, S.M.; Olshan, A.F.; Savitz, D.A.; Thorp, J.; Erichsen, H.C.; Chanock, S.J. 2004: Anti-inflammatory cytokine polymorphisms and risk of small-for-gestational age or spontaneous preterm birth. American Journal of Epidemiology 159(11, Suppl S): S34

Vitkovic, L.; Maeda, S.; Sternberg, E. 2001: Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9(6): 295-312

Leinen, H.T.; Wuelknitz, P.; Jassoy, C. 2002: Anti-inflammatory dental care agents. Official Gazette of the United States Patent and Trademark Office Patents 1265(2)

Kim, H.J.; Ifergan, I.; Seguin, R.; Duddy, M.; Antel, J.; Bar Or, A. 2003: Anti-inflammatory differentiation of human monocytes and microglia induced by glatiramer acetate therapy A new look at bystander suppression. Neurology 60(5 Suppl 1): A394

Eisenbach Schwartz, M.; Beserman, P.; Hirschberg, D.L. 2000: Anti-inflammatory dipeptide and pharmaceutical composition thereof. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)

Gurfinkel, E.P.; Bozovich, G.E.; Litvak Bruno, M.R.; Schnidt, J.L.; Scazziota, A. 2000: Anti-inflammatory dosages of aspirin, or celecoxib, versus antithrombotic dose of aspirin for reducing acute silent ischemia. Circulation 102(18): 2; 500

Brunelleschi, S.; Lavagno, L.; Spina, S.; Colangelo, D.; Viano, I. 2003: Anti-inflammatory drugs and rheumatoid arthritis A role for TNF-alpha and NF-kB. British Journal of Pharmacology 138(Proceedings Suppl): 11P

D.S.Del Fiol, Fernando 2003: Anti-inflammatory drugs interference in absorption and distribution of amoxicillin. Journal of Clinical Pharmacology 43(9): 1022

Del Fiol, F.S.; Menon, S.Z.; Caramez, T.H.; Celotto, T.F.; Lopes, R.A.S. 2002: Anti-inflammatory drugs interference in absorption and tissue penetration of amoxycillin. International Journal of Antimicrobial Agents 19(Suppl 1): S90-S91

Wunsch, H. 1999: Anti-inflammatory drugs may be underused in cystic fibrosis. Lancet (North American Edition) 353(9161): 1335

Singh, R.K.; Pandey, B.L.; Tripathi, M.; Pandey, V.B. 2001: Anti-inflammatory effect of (+)-pinitol. Fitoterapia 72(2): 168-170

Burger, D.; Brunner, F.; Modoux, C.; Dayer, .M. 1999: Anti-inflammatory effect of IFN-beta by two concurrent pathways on human lymphocytes and monocytes, respectively. Cytokine 11(11): 926

Wilson, H.M.; Rees, A.J.; Kluth, D.C. 2003: Anti-inflammatory effect of NF-kappaB inhibited macrophages on glomerular inflammation. Journal of the American Society of Nephrology 14(Abstracts Issue): 173A

Irie, K.; Suganuma, T.; Yoshioka, T.; Fujii, E.; Kase, R.; Muraki, T. 2002: Anti-inflammatory effect of a Rho kinase inhibitor, Y27632, on the lipopolysaccharide -induced increase in vascular permeability in mice. Japanese Journal of Pharmacology 88(Suppl 1): 122P

Glibetic, M.; Parker, J.; Aranda, J.V. 1999: Anti-inflammatory effect of acetaminophen via suppression of nitric oxide synthase induction by Group B Streptococci. Pediatric Research 45(4 Part 2): 66A

Trifilieff, A.; Corteling, R.; Wyss, D.; Fuentes, M.; Bertrand, C. 2000: Anti-inflammatory effect of an inducible nitric oxide inhibitor in murine allergen-induced airway inflammation Mechanism of action. British Journal of Pharmacology 131(Proceedings Suppl): 116P

Meister, D.; Aldhous, M.C.; Bode, J.; Shand, A.; Johnson, W.; Giffen, S.; Ghosh, S. 2001: Anti-inflammatory effect of elemental diet in vitro depends on fatty acid composition. Gut 48(Suppl 1): A2

Stoll, L.L.; Li, W.G.; Spector, A.A.; Weintraub, N.L. 2001: Anti-inflammatory effect of epoxyeicosatrienoic acids on endotoxin-induced IL-8 production in human endothelial cells. Circulation 104(17): 2; 171

Dimitrijevic, M.; Stanojevic, S.; Miletic, T.; Kovacevic Jovanovic, V.; Radulovic, J.; Vujic Redzic, V. 1999: Anti-inflammatory effect of intraplantary administered metionine-enkephalin on rat paw edema. Neuroimmunomodulation 6(6): 469

Guillen, C.; Mcinnes, I.B.; Van Berkel, P.; Brock, J.H. 2000: Anti-inflammatory effect of lactoferrin in mouse models of arthritic disease. Shimazaki, Kei-ichi Author, Tsuda, Hiroyuki Author, Tomita, Mamoru Author, Kuwata, Tamotsu Author, Perraudin, Jean-Paul Author International Congress Series; Lactoferrub: Structure, function and applications 103-109

Narender, N.; Shailendra, G.; Avtar, S.; Inderjit, S. 2003: Anti-inflammatory effect of lovastatin in multiple sclerosis by inducing Th2 immune responses involving GATA3/STAT6 transcription. Journal of Neurochemistry 87(Suppl 1): 98

Wang, Y.-H.; Bai, C.-X.; Hong, Q.-Y.; Chen, J. 2003: Anti-inflammatory effect of methoxyphenamine compound in rat model of chronic obstructive pulmonary disease. Acta Pharmacologica Sinica 24(12): 1324-1327

Yoo, E.S.; Kang, H.K.; Park, J.S.; Cho, J.Y. 2001: Anti-inflammatory effect of newly synthesized tumor necrosis factor-alpha, D-297. Journal of Leukocyte Biology Suppl: 80

Brodsky, B.; Wormser, U. 2003: Anti-inflammatory effect of parenterally injected H2A histone fragment against sulfur mustard-induced skin lesions. Toxicological Sciences 72(S-1): 162

Ikeda, M.; Hirose, Y.; Hamada, R.; Seike, M.; Matsumoto, M.; Kodama, H. 2003: Anti-inflammatory effect of peroxisome proliferator-activated receptor agonists through the suppression of nuclear factor kappaB in human epidermal keratinocytes. Journal of Investigative Dermatology 121(1): 0054

Makiyama, K.; Takeshima, F.; Kawasaki, H.; Zea-Iriarte, W.L. 2000: Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative. American Journal of Gastroenterology 95(7): 1838-1839

Ikeguchi, H.; Maruyama, S.; Morita, Y.; Kondo, C.; Mizuno, M.; Natori, Y.; Yuzawa, Y.; Matsuo, S. 2000: Anti-inflammatory effect of soluble thrombomodulin is mediated by thrombin activatable fibrinolysis inhibitor in rat thrombotic glomerulonephritis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 490A

Filippi, C.; Origlia, N.; Migliori, M.; Sarnico, I.; Panichi, V.; Taccola, D.; Bertelli, A.A.E.; Palla, R.; Giovannini, L. 2002: Anti-inflammatory effect of some natural phenolic compounds both in vitro and in a rat model of acute renal failure. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 209

Frieri, M.; May, B. 2003: Anti-inflammatory effect of tecastemizole on nasal epithelial cell production of IL-8, IL-1beta, and nitric oxide. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S216-S217

Legora, A.M.; Castro, P.; Lima, L.M.; Lugnier, C.; Barreiro, E.J.; Goncalves, D.M.raes, V.L. 2001: Anti-inflammatory effect of thalidomide-derived compounds on LPS-induced inflammation in mouse lung. Inflammation Research 50(Suppl 3): S206

Wu, D.-m.; Duan, W.-q.; Liu, Y.; Cen, Y. 2010: Anti-inflammatory effect of the polysaccharides of golden needle mushroom in burned rats. International Journal of Biological Macromolecules 46(1): 100-103

Bessis, N.; Guery, L.; Mantovani, A.; Vecchi, A.; Fradelizi, D.; Boissier, M.C. 2000: Anti-inflammatory effect of the type II decoy receptor in experimental arthritis. Immunology Letters 73(2-3): 158

Pruefer, D.; Novak, J.; Makowski, J.; Dahm, M.; Guth, S.; Oelert, H.; Buerke, M. 2003: Anti-inflammatory effects by the translation inhibitor rapamycin following ischemia and reperfusion. FASEB Journal 17(4-5): Abstract 655

Dharmasiri, M.G.; Thabrew, M.I.; Ratnasooriya, W.D. 2000: Anti-inflammatory effects of Anisomeles indica. Phytomedicine 7(Suppl 2): 97

Kim, K.; Han, S.; Song, Y.; Park, E.; Yun, Y.; Ha, N.J.; Cho, K. 2004: Anti-inflammatory effects of CMSK by suppressing protein expression of pro-inflammatory cytokines in vivo and in vitro. FASEB Journal 18(4-5): Abstract 329

Choudhury, B.K.; Klinman, D.; Wild, J.S.; Sur, N.; Alam, R.; Sur, S. 1999: Anti-inflammatory effects of CpG ODN in a murine model of asthma A critical role for IFN-gamma. Journal of Allergy and Clinical Immunology 103(1 Part 2): S208

Fiebich, B.; Kammerer, N. 2000: Anti-inflammatory effects of Harpagophytum lysates. Phytomedicine 7(Suppl 2): 40

Alabanza, P.L.; Woraratanadharm, J.; Kozaiwa, K.; Huybrechts, M.M.; Fox, L.M.; Nast, C.C.; Pizarro, T.T. 1999: Anti-inflammatory effects of IL-1 receptor antagonist gene therapy in experimental rabbit colitis. Gastroenterology 116(4 Part 2): A660

Duan, W.; Chan, H.; Vlahos, C.; Wong, W. 2004: Anti-inflammatory effects of LY294002, a PI3K inhibitor, in a mouse model of asthma. Journal of Allergy and Clinical Immunology 113(2 Suppl): S219

Georgewill,O.A.; Georgewill,U.O.; Nwankwoala,R.N.P. 2010: Anti-inflammatory effects of Morninga oleifera lam extract in rats. Asian Pacific Journal Of Tropical Medicine: 2, 133-135

Corbel, M.; Germain, N.; Boichot, E.; Burgaud, J.L.; Lagente, V. 2001: Anti-inflammatory effects of NCX-950, a nitric oxide releasing derivative of salbutamol, in lipopolysaccharide -induced acute lung injury in mice. Inflammation Research 50(Suppl 3): S204

Frode, T.S.; Vargas, A.; Geremias, D.S.; Gossman, G.; Schenkel, E.; Medeiros, Y.S.; Reginatto, F.H.; Fornari, P.E.; Provensi, G. 2004: Anti-inflammatory effects of Passiflora edulis Sims on the mouse model of pleurisy induced by carrageenan. Clinical Chemistry 50(6, Suppl S, Part 2): A36-A37

LeeChiaJung; ChenLihGeeng; LiangWenLi; WangChingChiung 2010: Anti-inflammatory effects of Punica granatum linne in vitro and in vivo. Food Chemistry 8(2): 315-322

Singh, B.; Srinivasan, B.; Ploutz Snyder, R.J.; Schroeder, E.T.; Narsipur, S.S. 2002: Anti-inflammatory effects of Simvastatin in patients with end stage renal disease. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 556A

Hicks, A.E.; Ridger, V.C.; Dixon, R.; Dupre, B.; Hellewell, P.G.; Norman, K.E. 2000: Anti-inflammatory effects of TBC1269 are not due to competitive inhibition of leukocyte rolling. FASEB Journal 14(4): A43

Colombo, G.; Buffa, R.; Bardella, M.Teresa.; Garofalo, L.; Carlin, A.; Lipton, J.M.; Catania, A. 2003: Anti-inflammatory effects of alpha-melanocyte-stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10(4): 208-216

Min, K.R.; An, K.Y.; Lee, D.G.; Hwang, D.H.; Lee, S.H.; Kim, Y. 2000: Anti-inflammatory effects of alpha-viniferin and resveratrol. Phytomedicine 7(Suppl 2): 97-98

Shimazaki, J.; Shimmura, S.; Inoue, H.; Tsubota, K. 2000: Anti-inflammatory effects of amniotic membrane grafting in ocular surface disorders. IOVS Investigative Ophthalmology and Visual Science 41(4): S453

Ishida, T.; Yarimizu, K.; Gute, D.C.; Korthuis, R.J. 2000: Anti-inflammatory effects of calcium preconditioning Role of protein kinase C. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A827

Curran, N.; Brady, K.J.; Fitzgerald, S.N.; Moynagh, P.N. 2003: Anti-inflammatory effects of cannabinoid receptor ligands in glial cells. European Cytokine Network 14(Suppl 3): 125

Hamalainen, M.; Lahti, A.; Moilanen, E. 2002: Anti-inflammatory effects of cyclosporin A. Nitric Oxide 6(4): 398

Sagin, F.G.; Sozmen, E.Y. 2004: Anti-inflammatory effects of dietary antioxidants. Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents 3(1): 19-30

Gielen, S.; Adams, V.; Erbs, S.; Linke, A.; Riedel, B.; Schuler, G.; Hambrecht, R. 2001: Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. European Heart Journal 22(Abstract Suppl): 405

Tachibana, A.; Kimura, H.; Kozawa, K.; Morikawa, A.; Kato, M. 2004: Anti-inflammatory effects of fenoterol on human eosinophils and neutrophils A possible mechanism of 2-adrenoceptor-independent effects. International Archives of Allergy and Immunology 134(Suppl 1): 44-45

Mcmillan, S.J.; Escott, K.J.; Webber, S.E.; Foster, M.L.; Sargent, C.A. 2000: Anti-inflammatory effects of heat-killed Mycobacterium vaccae in murine antigen-induced airway inflammation. British Journal of Pharmacology 129(Proceedings Suppl): 27P

Shimizu, T.; Kita, H. 2001: Anti-inflammatory effects of heparin on human eosinophils. Journal of Allergy and Clinical Immunology 107(2): S32

Molnar, C.; Kaser, A.; Tilg, H.; Garcia Trevijano, E.R.; Mato, J.M.; Avila, M.A.; Gabay, C. 2002: Anti-inflammatory effects of hepatocyte growth factor Induction of interleukin-1 receptor antagonist in murine hepatocytes and human hepatoma cells. Hepatology 36(4 Part 2): 332A

Ogura, S.; Nakano, M.; Aibiki, M.; Cook, J.A.; Ogli, K. 2000: Anti-inflammatory effects of human anti-thrombin III on rat shock. Journal of Endotoxin Research 6(2): 166

Lindegaard, C.; Gleerup, K.B.; Thomsen, M.H.; Martinussen, T.; Jacobsen, S.; Andersen, P.H. 2010: Anti-inflammatory effects of intra-articular administration of morphine in horses with experimentally induced synovitis. American Journal of Veterinary Research 71(1): 69-75

Chacko, B.; Chandler, R.; Mundhekar, A.; Pruitt, H.; Ramachandran, A.; Barnes, S.; Patel, R. 2003: Anti-inflammatory effects of isoflavones Role of flow, PPARgamma and glycosylation. Free Radical Biology and Medicine 35(Suppl 1): S33

Taechowisan,T.; Wanbanjob,A.; Tuntiwachwuttikul,P.; LiuJiKai 2010: Anti-inflammatory effects of lansai C and D cause inhibition of STAT-1 and NF- kappa B activations in LPS-induced RAW 2647 cells. Food And Agricultural Immunology: 1, 57-64

Frode, T.S.; Dalmarco, E.M.; Farges, R.C.; Spillere Silva, M.B.; Medeiros, Y.S. 2003: Anti-inflammatory effects of methotrexate, cyclosporine A, Ro5-4864 and PK11195 in the mouse model of pleurisy induced by carrageenan. Clinical Chemistry 49(S6): A154

Wu, A.Y.ung Yuen; Li, W. 2002: Anti-inflammatory effects of montelukast in a mouse model of asthma. Journal of Allergy and Clinical Immunology 109(1 Suppl): S25

Kent, S.; Johnson, L. 1999: Anti-inflammatory effects of n-3 fatty acids Interactions with tumor necrosis factor and stress. Society for Neuroscience Abstracts 25(1-2): 699

Getting, S.J.; Flower, R.J.; Perretti, M. 2000: Anti-inflammatory effects of natural and synthetic agonists of the melanocortin type 3 receptor. Inflammation Research 49(Suppl 2): S87

Collier, L.S.; Gewirtz, A.T.; Karmali, V.; Madara, J.L.; Neish, A.S. 2001: Anti-inflammatory effects of nonpathogenic Salmonella are protein synthesis-independent but require cell contact and type III secretion. Gastroenterology 120(5 Suppl 1): A 326

Mabley, J.G.; Pacher, P.; Baloglu, E.; Jagtap, P.; Salzman, A.L.; Southan, G.J.; Szabo, C. 2003: Anti-inflammatory effects of novel, potent isoindolinone inhibitors of PARP. FASEB Journal 17(4-5): Abstract 866

Martyushev Poklad, A.V.; Pashinskiy, V.G.; Sergeeva, S.A.; Dygai, A.M.; Epstein, O.I. 2003: Anti-inflammatory effects of oral ultra-low doses of anti-TNFalpha Experimental findings. Inflammation Research 52(Suppl 2): S 158

Sethi, S.; Chaudhary, A.; Mishra, A. 2004: Anti-inflammatory effects of oxidized omega-3 fatty acids are mediated through inhibition of NF- kappa B via a PPAR alpha dependent pathway. FASEB Journal 18(4-5): Abstract 44

Malapel, M.; Dharancy, S.; Roskams, T.; Auwerx, Y.; Desreumaux, P. 2002: Anti-inflammatory effects of peroxisome proliferator activated receptor -GAMMA in CCl4-induced hepatitis. Hepatology 36(4 Part 2): 240A

Malapel, M.; Dharancy, S.; Roskams, T.; Auwerx, J.; Mathurin, P.; Desreumaux, P. 2004: Anti-inflammatory effects of peroxysome proliferator- activated receptor gamma in CCI4- induced hepatitis. Mediators of Inflammation 13(1): 62

Hashioka, S.; Monji, A.; Nakanishi, H. 2003: Anti-inflammatory effects of phospatydilserine -liposomes in amyloid- beta peptide -activated microglia. Journal of Pharmacological Sciences 91(Suppl I): 209P

Parissis, J.T.; Adamopoulos, S.; Karatzas, D.; Kroupis, C.; Georgiadis, M.; Karavolias, G.; Koniavitou, K.; Karas, S.; Coats, A.J.S.; Kremastinos, D. 2001: Anti-inflammatory effects of physical training are associated with improvement in endothelial function of chronic heart failure patients. European Heart Journal 22(Abstract Suppl): 684

Sigg, D.C.; Mcclay, C.B.; Petersen, M.G. 2003: Anti-inflammatory effects of rapamycin. FASEB Journal 17(4-5): Abstract 409

Moreno Manzano, V.; Sepulveda Munoz, J.C.; Lopez Ongil, S.; Martinez, J.A.; Diez Marques, L.; Rodriguez Puyol, M.; Lucio Cazana, F.J. 1999: Anti-inflammatory effects of retinoids on cultured human mesangial cells. Nephrology Dialysis Transplantation 14(9): A14

Lin, Q.; Ma, J.; Gu, Y.; Liu, S.; Lin, S. 2003: Anti-inflammatory effects of rosiglitazone on obstructed kidneys. Journal of the American Society of Nephrology 14(Abstracts Issue): 641A

Odashima, M.; Linden, J.; Kozaiwa, K.; Rivera Nieves, J.; Sugawara, K.; Moskaluk, C.A.; Nast, C.C.; Matsumoto, S.; Cominelli, F. 2001: Anti-inflammatory effects of selective A2A adenosine receptor agonism in experimental inflammatory bowel disease. Gastroenterology 120(5 Suppl 1): A 280

Patel, R.P.; Chandler, R.T.; Kevil, C.G.; Kucik, D.; Boersma, B.; Barnes, S.; Darley Usmar, V. 2001: Anti-inflammatory effects of soy-isoflavones Inhibition of Leukocyte-endothelial interactions. Free Radical Biology and Medicine 31(10): S35

Tardif, J.C.; L'allier, P.L.; Schwartz, L.; Title, L.; Laramee, L.; Reeves, F.; Lavoie, J.; Guertin, M.C.; Gregoire, J. 2004: Anti-inflammatory effects of the V-protectant AGI-1067 in the Canadian antioxidant restenosis trial. Journal of the American College of Cardiology 43(5 Suppl A): 253A

Sherling, M.A.; Theodoridis, E.; Filler, R.; Hayday, A.; Tigelaar, R.; Girardi, M. 2002: Anti-inflammatory effects of thymosin-beta4 splice variants in the skin. Journal of Investigative Dermatology 119(1): 344

Liu, S.Q.; Tieche, C.; Alkema, P.K.; Liu, D.Z. 2003: Anti-inflammatory effects of vascular elastin matrix. Circulation 108(17): IV24

Fiebich, B.L.; Appel, K. 2003: Anti-inflammatory effects of willow bark extract. Clinical Pharmacology and Therapeutics 74(1): 96; Author Reply 96-7

Bonaterra, G.A.; Kelber, O.; Kinscherf, R.; Harsch, J.; Weiser, D.; Metz, J. 2004: Anti-inflammatory effects of willow bark extract STW 33-I in lipopolysacharide activated human monocytes. Naunyn-Schmiedeberg's Archives of Pharmacology 369(Suppl 1): R10

Harris, M.; Surguladze, D.; Dyakonov, T.; Riggs, J.; Ansari, A.; Anderson, W.; Myung, S.; Smalley, M.; Ekwuribe, N. 2000: Anti-inflammatory efficacy and acute gastrointestinal irritancy profile for a series of novel 6-methoxy-2-naphthylacetic acid -pro-drugs. Inflammation Research 49(Suppl 2): S97

Wang, P.; Corvalan, J.R.F.; Davis, C.G.; Yang, X.D. 2001: Anti-inflammatory efficacy of ABX-IL8, a fully human anti-interleukin-8 monoclonal antibody. FASEB Journal 15(4): A362

Miyake, K.; Tsuriya, Y.; Yageta, H.; Suzuki, H.; Toyoda, Y. 2002: Anti-inflammatory eye drop. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)

Zhang, H.; Guo, J.; Guan, H.; Li, L. 2002: Anti-inflammatory factor in bovine colostrum. Journal of Dairy Science 85(Suppl 1): 287

Ding, A.; Zhu, J.; Jin, F.; Grobmyer, S.R.; Nathan, C.F. 1999: Anti-inflammatory function of secretory leukocyte protease inhibitor. Journal of Endotoxin Research 5(3): 167-169

Virella Lowell, I.; Mason, E.; Ferkol, T.; Flotte, T.R. 2001: Anti-inflammatory gene therapy for cystic fibrosis with rAAV-IL-10. Pediatric Research 49(4 Part 2): 458A

Adorini, L.; Martino, G. 1999: Anti-inflammatory gene therapy of demyelinating diseases. Journal of Autoimmunity (Suppl ): 39

Kettle, J.; Faull, A.W. 2003: Anti-inflammatory indole derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1270(4)

Girndt, M.; Kaul, H.; Sester, U.; Ulrich, C.; Sester, M.; Kohler, H. 2002: Anti-inflammatory interleukin-10 genotype Two year follow-up data of prospective study show predictive value for cardiovascular mortality in dialysis patients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 56A

Kim, H.Y.; Park, S.J.; Park, E.J.; Joe, E.H.; Jou, I. 2003: Anti-inflammatory mechanisms of curcumin and PPAR-Na agonists through suppression of Janus kinase-STAT pathways in membrane raft. Journal of Leukocyte Biology Suppl: 30

Molnar, C.; Kaser, A.; Tilg, H. 1999: Anti-inflammatory mechanisms of hepatocyte growth factor Induction of interleukin-1 receptor antagonist. Hepatology 30(4 Part 2): 377A

Khan, D.A.; Gruchalla, R.S.; Millard, M.W.; Wasserman, R.L.; Kennerly, D.A. 2000: Anti-inflammatory medication use for persistent asthma in Dallas Results of a Dallas Asthma Consortium survey. Journal of Allergy and Clinical Immunology 105(1 part 2): S317

Fridkin, M.; Yavin, E. 2003: Anti-inflammatory peptides derived from C-reactive protein. Official Gazette of the United States Patent and Trademark Office Patents 1268(1)

Woolfe, A.J.; Mcintyre, G.; Sheth, N.V. 2001: Anti-inflammatory pharmaceutical formulations. Official Gazette of the United States Patent and Trademark Office Patents 1252(3)

Cuendet, M.; Pezzuto, J.M. 2001: Anti-inflammatory phytochemicals. Abstracts of Papers American Chemical Society 222(1-2): AGFD127

Maw, G.N. 2003: Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)

Talmadge, J.E. 1999: Anti-inflammatory polypeptide antagonists of human I1-8. Official Gazette of the United States Patent and Trademark Office Patents 1223(3)

Bianchi, A.; Moulin, D.; Boyault, S.; Poleni, P.E.; Bordji, K.; Netter, P.; Jouzeau, J.Y.; Terlain, B. 2004: Anti-inflammatory potency of PPARgamma ligands in articular cells. Mediators of Inflammation 13(1): 56

Kiemer, A.K.; Huber, C.; Baron, A.; Vollmar, A.M. 2000: Anti-inflammatory potential of Phyllanthus amarus inhibition of iNOS and COX-2 in murine macrophages and in isolated rat Kupffer cells. Phytomedicine 7(Suppl 2): 125

Skottner, A.; Post, C.; Ocklind, A.; Seifert, E.; Liutkevicius, E.; Meskys, R.; Pilinkiene, A.; Biziuleviciene, G.; Lundstedt, T. 2003: Anti-inflammatory potential of melanocortin receptor-directed drugs. Annals of the new York Academy of Sciences 994: 84-89

Chan, Y-Yi.; Li, C-Hao.; Shen, Y-Chiang.; Wu, T-Shung. 2010: Anti-inflammatory principles from the stem and root barks of Citrus medica. Chemical and Pharmaceutical Bulletin 58(1): 61-65

Carty, E.; Macey, M.; Van Nueten, L.; Rampton, D.S. 1999: Anti-inflammatory profile in vitro of ridogrel, a putative new treatment for inflammatory bowel disease. Gut 44(Suppl 1): A36

Lucas, R.; Ubeda, A.; Alves, M.; Del Olmo, E.; San Feliciano, A.; Paya, M. 2000: Anti-inflammatory profile of a lipidic amidoalcohol, a novel inhibitor of cytosolic phospholipase A2. Methods and Findings in Experimental and Clinical Pharmacology 22(6): 510

Yadav, P.N.; Liu, Z.; Rafi, M.M. 2003: Anti-inflammatory properties of a diarylheptanoid from Ginger are mediated through Erk1/2-NF-kB signaling pathway. Proceedings of the American Association for Cancer Research 44: 251

Maric, I.; Poljak, L.J.; Zoricic, S.; Bobinac, D.; Bosukonda, D.; Sampath, K.; Vukicevic, S. 2002: Anti-inflammatory properties of bone morphogenetic protein-7 might be beneficial in the treatment of intestinal bowel disease. Calcified Tissue International 70(4): 270

Agrawal, D.K.; Berro, A.; Kreutner, W.; Townley, R.G. 2000: Anti-inflammatory properties of desloratadine Effect on eosinophil chemotaxis, adhesion and release of superoxide anions. Journal of Allergy and Clinical Immunology 105(1 part 2): S16-S17

Kojic, L.; Zhang, J.; Goutsos, T.; Sanghera, A.; Zhang, Z.; Jabali, M.; Costello, P.C.; Baybik, J.; Yoganathan, N.; Leung, D.; Dedhar, S.; Sanghera, J. 2001: Anti-inflammatory properties of integrin-linked kinase 1 inhibitors. Inflammation Research 50(Suppl 3): S160

Razani Boroujerdi, S.; Kalra, R.; Knall, C.; Hahn, F.F.; Singh, S.P.; Langley, R.J.; Pena Philippides, J.C.; Sopori, M.L. 2003: Anti-inflammatory properties of nicotine Nicotine inhibits the migration of leukocytes to the site of inflammation. Experimental Lung Research 29(Suppl 1): 102-103

Shimoda,H.; ShanShaoJie; Tanaka,J.; Seki,A.; SeoJoungWook; Kasajima,N.; Tamura,S.; KeYan; Murakami,N. 2010: Anti-inflammatory properties of red ginger extract and suppression of nitric oxide production by its constituents. Journal Of Medicinal Food: 1, 156-162

Nam, J.H.; Alnoah, Z.; Murthy, S.N. 2003: Anti-inflammatory properties of statins in the dextran sodium sulfate mouse model of colitis. American Journal of Gastroenterology 98(9 Suppl): S244

Musiek, E.; Milne, G.; Wang, D.; Zanoni, G.; Morrow, J. 2003: Anti-inflammatory properties of the cyclopentenone isoprostane 15-A2-IsoP. Free Radical Biology and Medicine 35(Suppl 1): S56

Greenspan, P.; Bauer, J.D.; Pollock, S.H.; Hargrove, J.L.; Hartle, D.K. 2004: Anti-inflammatory properties of the muscadine grape. FASEB Journal 18(4-5): Abstract 102

Harada, N.; Okajima, K.; Uchiba, M.; Isobe, H.; Kojima, T. 2003: Anti-inflammatory property of antithrombin is mainly mediated by stimulation of the sensory nerve-mediated anti-inflammatory pathway. Blood 102(11): 123b-124b

Latman, N. 2000: Anti-inflammatory steroid without glucocorticoid receptor binding or gene expression. FASEB Journal 14(4): A184

Rieckmann, P.; Mäurer, M. 2002: Anti-inflammatory strategies to prevent axonal injury in multiple sclerosis. Current Opinion in Neurology 15(3): 361-370

Egashira, K. 2002: Anti-inflammatory strategy for treatment of restenosis and atherosclerosis. Japanese Journal of Pharmacology 88(Suppl 1): 52P

Ryan, M.E.; Ramamurthy, N.S.; Lee, H.M.; Liu, Y.; Carnu, O.I.; Golub, L.M. 2003: Anti-inflammatory tetracyclines for the prevention of diabetic complications. Inflammation Research 52(Suppl 2): S 157

Aisen, P.S. 2000: Anti-inflammatory therapy for Alzheimer's disease. Neurobiology of Aging 21(3): 447-448; Discussion: 451-453

Matsumori, A. 2004: Anti-inflammatory therapy for heart failure. Current Opinion in Pharmacology 4(2): 171-176

Huse, D.M.; Russell, M.W.; Weiss, S.T.; Hartz, S.C. 1999: Anti-inflammatory therapy reduces total costs of asthma care compared to bronchodilation. Journal of Allergy and Clinical Immunology 103(1 Part 2): S74

Shaykhiev, R.R. 2001: Anti-inflammatory treatment with sodium cromoglycate in intermittent atopic asthma prevents the development of persistent disease. Inflammation Research 50(Suppl 3): S199

Mayer, A.; Gunasekera, S.P.; Pomponi, S.A.; Sennett, S.H. 2002: Anti-inflammatory uses of manzamines. Official Gazette of the United States Patent and Trademark Office Patents 1258(2)

Intahphuak, S.; Khonsung, P.; Panthong, A. 2010: Anti-inflammatory, analgesic, and antipyretic activities of virgin coconut oil. Pharmaceutical Biology 48(2): 151-157

RajuGautam; AmitSrivastava; Jachak,S.M.; ArvindSaklani 2010: Anti-inflammatory, cyclooxygenase -2, COX-1 inhibitory and antioxidant effects of Dysophylla stellata Benth. Fitoterapia 81(1): 45-49

Newmark, T.; Schulick, P. 2002: Anti-inflammatory, sleep-promoting herbal composition and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)

Baudino, M.D. 2000: Anti-inflammatory-agent-loaded catheter and method for preventing tissue fibrosis. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

Rojas, J.; Rutkoski, T.; Vennarini, J.; Jang, H.; Wagner, C.L. 2003: Anti-infliximab antibodies are eliminated more rapidly in vivo than non-immune antibodies in the presence of infliximab. FASEB Journal 17(7): C138

Hong Yuan, Li; Yi Shu, Yang; Mi Feng, Liu; Dian Li, Liu; Kun, Zhou; Kui Ming, Tong 2001: Anti-influenza Virus activity of a Chinese medicinal herb Antiviral Agent No1 in MDCK Culture. Antiviral Research 50(1): A86

Cai, J.; Furukawa, S.; Jones, D.P. 2000: Anti-influenza activity of glutathione. FASEB Journal 14(4): A493

Fedchuk, A.S.; Lozitsky, V.P.; Gridina, T.L.; Shitikova, L.I.; Palyi, G.K. 2003: Anti-influenza and anti-herpetic acitivity of decametoxin. Antiviral Research 57(3): A82

Tung, N.Huu.; Kwon, H-Joon.; Kim, J-Hong.; Ra, J.Chan.; Ding, Y.; Kim, J.Ah.; Kim, Y.Ho. 2010: Anti-influenza diarylheptanoids from the bark of Alnus japonica. Bioorganic and Medicinal Chemistry Letters 20(3): 1000-1003

Roberts, N.A. 2001: Anti-influenza drugs and neuraminidase inhibitors. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 56: 195-237

Kravchenko, I.; Alexandrova, A.; Lozitslcy, V.; Lozitskaya, R.; Larionov, V.; Ovcharenko, N. 2004: Anti-influenza rimantadine and novel phenol-contained compounds efficacy after transdermal delivery. Antiviral Research 62(2): A77

Johnston, S.L. 2002: Anti-influenza therapies. Virus Research 82(1-2): 147-152

Trzonkowski, P.; Szmit, E.; Wieckiewicz, J.; Mysliwska, J.; Foerster, J.; Mysliwski, A. 2000: Anti-influenza vaccination induces TH1-type cytokines in lymphocytes. Immunology Letters 73(2-3): 191

Szmit, E.; Trzonkowski, P.; Mysliwska, J.; Foerster, J.; Mysliwski, A. 2000: Anti-influenza vaccine-induced apoptosis is enhanced in the elderly. Immunology Letters 73(2-3): 227

Naumov, Y.ri, N.; Clute, Shalyn, C.; Watkin, Levi, B.; Selin, Liisa, K. 2003: Anti-influenza virus memory CD8 T cells exist as multiple clones with limited alpha/betaTCR structural diversity. FASEB Journal 17(7): C172

HuangSuQing; ZhangZhiXiang; LiYouZhi; LiYuXia; XuHanHong 2010: Anti-insect activity of the methanol extracts of fern and gymnosperm. Agricultural Sciences In China: 2, 249-256

Cozzie,L.R.; Irby,W.S. 2010: Anti-insect defensive behaviors in equines post-West Nile virus infection. Journal Of Veterinary Behavior: Clinical Applications And Research: 1, 13-21

Martinez,J.J.I. 2010: Anti-insect effects of the gall wall of Baizongia pistaciae , a gall-inducing aphid on Pistacia palaestina Boiss. Arthropod: 1, 29-34

Maruyama, T.; Murayama, H.; Nagata, A.; Shimada, A.; Kasuga, A.; Saruta, T. 2002: Anti-insulin-like growth factor-1 autoantibodies in type 1 diabetes. Annals of the new York Academy of Sciences 958: 267-270

Mousa, S.A. 2002: Anti-integrin as novel drug-discovery targets: potential therapeutic and diagnostic implications. Current Opinion in Chemical Biology 6(4): 534-541

Elkabes, B.; Semra, S.; Suoglu, O.S.; Tulin, O.; Saner, G. 2001: Anti-interferon alpha antibodies in children with chronic viral hepatitis. Journal of Hepatology 34(Suppl 1): 31-33

Gomez Amat, K.; Bello, I.; Cervantes, M.; Perez, J.; Lopez Saura, P. 1999: Anti-interferon alpha-2 autoantibodies in myasthenia gravis patients. Journal of Interferon and Cytokine Research 19(Suppl 1): S83

Skurkovich, S.; Boiko, A.; Buglak, A.; Beliaeva, I.; Alekseeva, T.; Smirnova, N.; Skurkovich, B. 1999: Anti-interferon-gamma abs slows disease progression in secondary progressive multiple sclerosis. Journal of Interferon and Cytokine Research 19(Suppl 1): S84

Skurkovich, S.V.; Skurkovich, B. 2002: Anti-interferon-gamma antibodies as a universal treatment for TH1 autoimmune diseases. Journal of Interferon and Cytokine Research 22(Suppl 1): S-190-S-191

Liu, Z.; Colpaert, S.; Overbergh, L.; Heremans, H.; Ceuppens, J.L.; Geboes, K.; Rutgeerts, P.J. 2000: Anti-interleukin 12 antibody prevents experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A576

Ford, J.; Pace, A. 2001: Anti-interleukin-1 receptor antagonist antibodies and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1250(4)

Dayer, J.M.; Feige, U.; Edwards, C.K.; Burger, D. 2001: Anti-interleukin-1 therapy in rheumatic diseases. Current Opinion in Rheumatology 13(3): 170-176

Van Gelder, T.; Warlé, M.; Ter Meulen, R.G. 2004: Anti-interleukin-2 receptor antibodies in transplantation: what is the basis for choice?. Drugs 64(16): 1737-1741

Renninger, M.L.; Sundberg, J.P.; Hogenesch, H. 2004: Anti-interleukin-5 decreases dermal eosinophilia but increases epidermal hyperplasia in chronic proliferative dermatitis mice. Journal of Investigative Dermatology 122(3): A14

Smith, P.C.; Dai, J.; Keller, E.T. 2000: Anti-interleukin-6 antibody enhances chemotherapeutic-mediated inhibition of prostate cancer cell growth in vitro. Proceedings of the American Association for Cancer Research 41: 528-529

Kovacs, E.J.; Duffner, L.A.; Gregory, M.S. 1999: Anti-interleukin-6 antibody treatment restores some but not all immune functions after thermal injury. Cytokine 11(11): 967

Smith, P.C.; Keller, E.T. 2001: Anti-interleukin-6 monoclonal antibody inhibits prostate cancer growth in vivo. Proceedings of the American Association for Cancer Research 42: 288

Wallner, L.; Smith, P.C.; Dai, J.; Dunn, R.; Zhang, J.; Murtha, J.; Yao, Z.; Keller, E.T. 2003: Anti-interleukin-6 monoclonal antibody reduces progression of androgen independent human prostate cancer xenografts in nude mice. Proceedings of the American Association for Cancer Research 44: 456

Ito, H. 2003: Anti-interleukin-6 therapy for Crohn's disease. Current Pharmaceutical Design 9(4): 295-305

Kurdowska, A.; Miller, E.J.; Alden, S.M.; Noble, J.M.; Harmon, C. 2000: Anti-interleukin-8 autoantibody is an important modulator of IL-8 function in the lung. FASEB Journal 14(4): A178

Kumar, R.; Adam, L.; Mandal, M.; Mendelsohn, J. 2002: Anti-invasive action of anti-EGF receptor antibody C225 Suppression of focal-adhesion kinase/B-catenin signaling components. Proceedings of the American Association for Cancer Research 43: 581

Mazar, A.P.; Jones, T.R. 2004: Anti-invasive and anti-angiogenic compositions. Official Gazette of the United States Patent and Trademark Office Patents 1279(4)

Mazar, A.P.; Jones, T.R. 1999: Anti-invasive and anti-angiogenic compositions and methods. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Muizzuddin, N.; Marenus, K.D.; Maes, D.H. 2004: Anti-irritating rosacea treatment. Official Gazette of the United States Patent and Trademark Office Patents 1278(3)

Dabrowski, R.; Malczewska, B.; Kosmicki, M.; Kowalik, I.; Pasierski, T. 2003: Anti-ischaemic effect of angiotensin-converting enzyme inhibitor, but not vitamin C in patients with coronary artery disease treated with beta-blockers and nitrates Randomised, cross-over double-blind comparison. European Heart Journal 24(Abstract Suppl): 655

Van Den Heuvel, A.F.M.; Dunselman, P.H.J.M.; Kingma, T.; Boomsma, F.; Verhorst, P.; Van Veldhuisen, D.J. 2000: Anti-ischaemic effects of ACE-inhibition with enalapril during long-term treatment in patients with coronary artery disease and normal left ventricular function. European Heart Journal 21(Abstract Suppl): 364

Michiels, C.; Redon, M.; Remacle, J. 2004: Anti-ischemic compounds. Official Gazette of the United States Patent and Trademark Office Patents 1285(4)

Hamman, R.F.; Shetterly, S.M.; Norris, J.M. 1999: Anti-islet antibodies in Hispanic and non-Hispanic white persons with adult onset diabetes The San Luis Valley Diabetes Study. Diabetes 48(Suppl 1): A75-A76

Garrett, Kurt Anthony 2002: Anti-jaundice composition for corpses and method. Official Gazette of the United States Patent and Trademark Office Patents 1258(2)

Mahana, W.; Samaan, A.; Kindt, T.J. 1999: Anti-keratin and anti-thyroglobulin autoimmune response in HTLV-I infected rabbits. FASEB Journal 13(4 Part 1): A631

Zhang, C.Y.; Rosen, A.; Matsumoto, A.K. 1999: Anti-keratin antibodies and disease activity in patients with rheumatoid arthritis. Arthritis and Rheumatism 42(9 Suppl): S134

Yu, H.; Wu, C.; Li, Y. 2002: Anti-keratinocyte IgG antibodies in vitiligo stimulate nerve growth factor release from UVB-treated cultured keratinocytes and reveal a photoprotective effect. Journal of Investigative Dermatology 119(1): 333

Ly, A.; Roth, B.; Causeret, A.S.; Jullien, D.; Kanitakis, J.; Faure, M.; Claudy, A. 2002: Anti-laminin 5 pemphigoid and acquired haemophilia. British Journal of Dermatology 146(6): 1104-1105

Barbosa, S.D.S.; Riederer, I.; Lima Quaresma, K.R.F.; Savino, W. 1999: Anti-laminin antibody blocks heart graft rejection triggered by T cells from Trypanosoma cruzi-infected mice Relationship with laminin-binding cytokines. Memorias do Instituto Oswaldo Cruz 94(Suppl 2): 43-44

Bandyopadhyay, S.; Pal, B.; Bhattacharya, S.; Ray, M.; Roy, K.C.andra 2003: Anti-leishmanial activity of betel leaf extract. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Drago, K.F.; Negrin, R.S. 2004: Anti-leukemic function of H60 specific cytotoxic T lymphocytes. FASEB Journal 18(4-5): Abstract 775

Balloy, V.; Sallenave, J.M.; Chignard, M. 2001: Anti-leukocyte elastase activity in airspaces during LPS-induced lung inflammation Role of DNA and polymorphonuclear neutrophils. Inflammation Research 50(Suppl 3): S180

Foster, P.; Mathur, A.; Mclean, P.; Perretti, M.; Moncada, S.; Ahluwalia, A.; Hobbs, A. 2003: Anti-leukocyte properties of a novel non NO-based soluble guanylate cyclase activator, BAY 41-2272. FASEB Journal 17(4-5): Abstract 655

Barnes, P.J. 2003: Anti-leukotrienes: here to stay?. Current Opinion in Pharmacology 3(3): 257-263

Calhoun, W.J. 2001: Anti-leukotrienes for asthma. Current Opinion in Pharmacology 1(3): 230-234

Sato, T.; Imai, N.; Sakiguchi, T.; Kitamura, K.; Kohno, Y.; Ito, A. 2000: Anti-lipogenic factors in cultured hamster sebocytes. Journal of Investigative Dermatology 115(3): 552

Edelson, B.T.; Cossart, P.; Unanue, E.R. 1999: Anti-listeriolysin O monoclonal antibody modulates Listeria infection in mice. FASEB Journal 13(4 Part 1): A630

Obermayer Straub, P.; Perardi, S.; Dostler, I.; Harms, A.; Kayser, A.; Vogel, A.; Jaeckel, E.; Strassburg, C.P.; Manns, M.P. 2000: Anti-liver cytosol type 1 autoantibodies correlate with a favourable prognosis in autoimmune hepatitis type 2. Hepatology 32(4 Pt 2): 164A

Goldenberg, D.M.; Qu, Z.; Horak, I.D.; Hansen, H.; Stein, R. 2003: Anti-lymphoma activity of a new humanized anti-CD20 monoclonal antibody, hA20. FASEB Journal 17(7): C123

Meyer Siegler, K.L.; Vera, P.L. 2003: Anti-macrophage migration inhibitory factor antibody in the rat bladder alters inflammatory gene expression profile induced by substance P. Journal of Urology 169(4 Suppl): 8

Leung, J.C.K.; Chan, L.Y.Y.; Tsang, A.W.L.; Tang, S.C.W.; Lai, K.N.ng 2003: Anti-macrophage migration inhibitory factor reduces transformating growth factor beta-1 expression in experimental IgA nephropathy. Journal of the American Society of Nephrology 14(Abstracts Issue): 408A

Pleass, R.J.; Mcguinness, D.H.; Holder, A.A.; Woof, J.M. 2002: Anti-malaria immune effector mechanisms recruited by human IgG1 and IgA1 monoclonal antibodies. Biochemical Society Transactions 30(3): A92

Milner, E.; McCalmont, W.; Bhonsle, J.; Caridha, D.; Cobar, J.; Gardner, S.; Gerena, L.; Goodine, D.; Lanteri, C.; Melendez, V.; Roncal, N.; Sousa, J.; Wipf, P.; Dow, G.Stuart. 2010: Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols. Malaria Journal 9: 51

Waters, N.C.; Yenesew, A.; Derese, S.; Midiwo, J.O.; Heydenreich, M.; Peter, M.G.; Akala, H.; Mwangi, J.; Wangui, J.; Liyala, P. 2003: Anti-malarial agents from Kenyan plants. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 485

Rathod, P.K. 2000: Anti-malarial composition and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1241(2)

Ulrich, P.C.; Cerami, A. 2004: Anti-malarial compounds, compositions and methods. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Nicholson, G.M.; Little, M.J.; Birinyi Strachan, L.C.; Szeto, T.H.; King, G.F.; Gordon, D. 2001: Anti-mammalian and anti-insect actions of delta-atracotoxins Spider toxins which target the voltage-gated sodium channel. Toxicon 39(2-3): 137

Thor Straten, P.; Guldberg, P.; Moerch, U.; Becker, J.C. 2000: Anti-melanocyte T cell responses - methodology versus biology. Journal of Investigative Dermatology 114(4): 738-739

Palermo, B.; Campanelli, R.; Garbelli, S.; Mantovani, S.; Lantelme, E.; Brazzelli, V.; Borroni, G.; Martinetti, M.; Necker, A.; Giachino, C. 2000: Anti-melanocyte T cells in vitiligo as the effective variant of an immune response that is often ineffective in melanoma. Tumori 86(4 Suppl 1): 5-6

Kawahara, A.; Shintani, N.; Hikosaka, A. 2001: Anti-metamorphic action of prolactin may be mediated by enhanced production of thyroid hormone-inactivating enzyme 5-deiodinase. Zoological Science 18: 10

Kashani Sabet, M.; Tu, G.; Liu, Y.; Debs, R. 2000: Anti-metastatic activity of hammerhead ribozymes targeting adhesion molecules in melanoma. Journal of Investigative Dermatology 114(4): 802

Tuszynski, G.P.; Rothman, V.L.; Actor, P.; Williams, T. 1999: Anti-metastatic activuty of thrombospondin-derived peptides. Proceedings of the American Association for Cancer Research 40: 598

Hu, Y.P.; Masin, D.; Tan, S.; Ng, R.; Yan, H.; Harasym, N.; Mayer, L. 2003: Anti-metastatic and anti-tumor efficacy of G3139, a Bcl-2 antisense oligonucleotide, as single agent or in combination with vinorelbin, in murine orthotopic and ectopic xenograft models of human non-small cell lung cancer. Proceedings of the American Association for Cancer Research 44: 1287-1288

Miki, T.; Fujiki, F.; Yano, S.; Nishioka, Y.; Sone, S. 2000: Anti-metastatic effect of IL-10 gene modification in human lung cancer cells is differentially regulated by organ microenvironments. Proceedings of the American Association for Cancer Research 41: 3

Amirkhosravi, A.; Francis, J.; Mousa, S. 2001: Anti-metastatic effect of low molecular weight heparin Tinzaparin and Tissue factor pathway inhibitor. Haemostasis 31(Suppl 1): 87

Watanabe, M.; Yazawa, H.; Back, T.; Subleski, J.; Wiltrout, R.; Ortaldo, J. 2004: Anti-metastatic effects of interleukin-12 gene therapy. FASEB Journal 18(4-5): Abstract 85

Griggs, D.W.; Shannon, K.E.; Keene, J.L.; Settle, S.L.; Duffin, T.D.; Nickols, M.A.; Schroeter, S.; Nickols, G.A.; Westlin, W.F. 2001: Anti-metastatic efficacy mediated by peptidomimetic alpha Vbeta3 integrin antagonists in orthotopic and experimental models. Proceedings of the American Association for Cancer Research 42: 263

Chaudhary, N.D.; Wu, M.; Mazurchuk, R.; Spernyak, J.; Veith, J.; Pera, P.; Greco, W.; Hoffman, R.M.; Kobayashi, T.; Bernacki, R.J. 2002: Anti-metastatic efficacy of CS-682 -N4-palmitoyl cytosine in orthotopic models demonstrated by high resolution magnetic resonance imaging. Proceedings of the American Association for Cancer Research 43: 60

Mccloskey, E.V.; Bal, S.; Tahtela, R.; Powles, T.; Paterson, A.G.; Kanis, J.A.; Ashley, S.; Tidy, A.; Atula, S.; Nevalainen, J. 2003: Anti-metastatic efficacy of clodronate is associated with a decrease in bone turnover. EJC Suppls 1(5): S127

Hanke, B.; Guggenbichler, P.J. 2004: Anti-microbial body care product. Official Gazette of the United States Patent and Trademark Office Patents 1281(2)

Depierro, K.J.; Christina Beck, L.; Niles, H.P.; Nabi, N.; Simone, A.J.; Curtis, J.P. 2004: Anti-microbial breath freshening mouthrinse. Official Gazette of the United States Patent and Trademark Office Patents 1281(3)

Burrell, R.E.; Morris, L.R. 2001: Anti-microbial coating for medical devices. Official Gazette of the United States Patent and Trademark Office Patents 1246(5)

Khanuja, S.P. Singh; Srivastava, S.; Kumar, T.R. Santha; Shasany, A.K.; Jain, D.C.; Darokar, M.P.; Saikia, D.; Kumar, S. 2002: Anti-microbial composition and method for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1260(4)

Clarkson, K.D.; Landa, A.S.; Makin, S.A.; Volker, A. 2004: Anti-microbial compositions. Official Gazette of the United States Patent and Trademark Office Patents 1286(3)

Hanninen, A.R.; Mikkola, J.; Kalkkinen, N.; Turjanmaa, K.; Reunala, T.; Palosuo, T. 2000: Anti-microbial plant proteins as allergens A study of PR3 and PR4 proteins. Journal of Allergy and Clinical Immunology 105(1 part 2): S54

Cummings, F.L.; Gottschling, P.; Hagerlin, J.R. 2000: Anti-microbial powder coatings. Official Gazette of the United States Patent and Trademark Office Patents 1236(4)

Cummings, F.L.; Gottschling, P.; Hagerlin, J.R.; Decker, O.H.; Sparks, M.A.ron 2002: Anti-microbial power coating. Official Gazette of the United States Patent and Trademark Office Patents 1261(2)

Krishna, B.R.; Lal, R.; Kishore, K. 2003: Anti-microbial properties of kava lactones. Journal of Clinical Pharmacology 43(9): 1027

Kragh, K.M.; Mikkelsen, J.D.; Nielsen, K.K. 2001: Anti-microbial proteins. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)

Williamson, R.R.; Derby, N.C.; Nickell, C.A. 2002: Anti-microbial socks and process for manufacture of same. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Horwitz, M.A.; Clemens, D.L. 2000: Anti-microbial targeting for intracellular pathogens. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)

Ofek, I.; Weiss, E.; Kashman, Y.; Goldhar, J.; Sharon, N. 2001: Anti-microbial-adhesion fraction derived from vaccinium. Official Gazette of the United States Patent and Trademark Office Patents 1251(3)

Corzani, I. 2002: Anti-microbic agent. Official Gazette of the United States Patent and Trademark Office Patents 1259(2)

Plouguerne,E.; Ioannou,E.; Georgantea,P.; Vagias,C.; Roussis,V.; Hellio,C.; Kraffe,E.; Stiger-Pouvreau,V. 2010: Anti-microfouling activity of lipidic metabolites from the invasive brown alga Sargassum muticum fensholt. Ine Biotechnology: 1, 52-61

Mcrae, A. 1999: Anti-microglial antibodies in cerebrospinal fluid of patients with neuropathologically confirmed Alzheimers disease. Society for Neuroscience Abstracts 25(1-2): 545

Plachetka, J.R. 2000: Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs. Official Gazette of the United States Patent and Trademark Office Patents 1234(2)

Matsumura, S.; Leung, P.S.C.; Van, D.W.ter, J.; Yamamoto, K.; Shiratori, Y.; Gores, G.J.; Ansari, A.A.; Coppel, R.L.; Gershwin, M.E.ic 2003: Anti-mitochondrial IgA antibody induces apoptosis to MDCK cells bearing human polymeric immunoglobulin receptor Evidence for AMA induced immunopathology. Hepatology 38(4 Suppl 1): 204A

Olafsson, S.; Gudjonsson, H.; Selmi, C.; Amano, K.; Invernizzi, P.; Podda, M.; Gershwin, M.E.ic 2003: Anti-mitochondrial antibodies in a genetically homogenous population of patients with primary biliary cirrhosis and relatives The case of Iceland. Hepatology 38(4 Suppl 1): 521A

Andrejevic, S.; Bukilica, M.; Bonaci Nikolic, B.; Bogdanovic, A.; Miljic, P. 2000: Anti-mitochondrial type 5 antibodies Possible protective marker for venous thrombosis?. Journal of Autoimmunity 15(2): A60

Suh, J.; Nicot, A.; Dicicco Bloom, E. 1999: Anti-mitogenic function and differential expression of the PACAP ligand/receptor system during cerebral cortex development. Society for Neuroscience Abstracts 25(1-2): 554

Drubin, D.G.; Hofmann, C.J. 2001: Anti-mitotic agent screening process. Official Gazette of the United States Patent and Trademark Office Patents 1251(2)

Pinney, K.G. 1999: Anti-mitotic agents which inhibit tubulin polymerization. Official Gazette of the United States Patent and Trademark Office Patents 1220(4): 3575

Webb, H.K.; Casero, R.A.; Woster, P.W. 1999: Anti-mitotic polyamine analogues effect tubulin dynamic. Proceedings of the American Association for Cancer Research 40: 285

Kawaguchi, E.; Shiozawa, H. 2000: Anti-mold and anti-bacteria air filter. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Vozzelli, M.A.; Mason, S.N.; Whorton, M.; Auten, R.L. 2001: Anti-monocyte chemoattractant protein-1 blocks hyperoxia-induced macrophage and neutrophil accumulation in newborn rat lung. Pediatric Research 49(4 Part 2): 270A

Hayashidani, S.; Tsutsui, H.; Shiomi, T.; Suematsu, N.; Weng, J.; Takeshita, A. 2001: Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after myocardial infarction. Circulation 104(17): 2; 214

Kataoka, C.; Usui, M.; Hiasa, K.I.; Egashira, K. 2001: Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes after balloon angioplasty in hypercholesterolemic rabbits and monkeys. Circulation 104(17): 2; 146

Ni, W.; Egashira, K.; Usui, M.; Inoue, S.; Kataoka, C.; Hiasa, K.I.; Zhao, Q.; Ishibashi, M.; Kitamoto, S. 2001: Anti-monocyte chemoattractant protein-1 gene therapy limits progression of established atherosclerosis to unstable plaques in apolipoprotein E-knockout mice. Circulation 104(17): 2; 146

Tada, S.; Nakamuta, M.; Tsuruta, S.; Ohta, S.; Fukutomi, M.; Kuniyoshi, M.; Enjoji, M.; Nawata, H. 2001: Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Hepatology 34(4 Pt 2): 381A

Ohtani, K.; Egashira, K.; Usui, M.; Kohjimoto, Y.; Kitajima, S.I.; Nakano, K.; Hirouchi, Y.; Kitamoto, S.; Takeshita, A. 2003: Anti-monocyte chemoattractant protein-1 therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys. Circulation 108(17): IV283

Rahbarizadeh, F.; Rasaee, M.J. 2000: Anti-morphine monoclonal antibody. Hybridoma 19(2): 197

Patterson, P.S.; Sacci, J.B.; Vaughan, J.A.; Paul, C.; Collins, W.E.; Wirtz, R.A.; Azad, A.F.; Lal, A.A. 2000: Anti-mosquito midgut monoclonal antibodies block development of Plasmodium falciparium and Plasmodium vivaxin mosquitoes and reduce vector fecundity and survivorship. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 215-216

Yo, Y.; Braun, M.; Owens, J.; Lu, H.; Mobaraki, H.; Kopp, J.B. 2000: Anti-mouse mesangial cell antiserum induces glomerulonephritis in vivo and mesangial cell necrosis in vitro. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 522A

Anonymous 2000: Anti-mucin: MAbs RT03, HTA, HM02, HM03. Hybridoma 19(6): 509

Mulders, Annemarie G.M.; Laven, Joop S.E.; Eijkemans, Marinus J.C.; De Jong, Frank H.; Themmen, Axel P.N.; Fauser, Bart C.J. 2003: Anti-mullerian hormone in normogonadotropic anovulatory infertility Evidence for retarded ovarian aging. Fertility and Sterility 80(Suppl 3): S270

Cremaschi, G.; Borda, T.; Sterin Borda, L. 1999: Anti-muscarinic acetylcholine receptor antibodies in patients with mental disorders Functional implications. Neuroimmunomodulation 6(6): 443

Temma, K.; Chugun, A.; Teraoka, T.; Teramoto, M.; Nagasaki, K.; Hara, Y.; Akera, T.; Sasaki, T.; Kondo, H. 1999: Anti-muscarinic action of mitoxantrone in guinea-pig hearts. Japanese Journal of Pharmacology 79(Suppl 1): 173P

Zhang, J.; Yang, Y.; Liang, X.M.; Chen, X.J.; Li, X.; Li, Z. 2003: Anti-mutation effects of lycopene on histidine-deficient Salmonella typhimurium strains. Toxicology 191(1): 57, September 15th

Yatvin, M.B.; Pederson, R.L. 2004: Anti-mycobacterial compositions. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Yatvin, M.B.; Pederson, R.L. 2003: Anti-mycobacterial compounds. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)

Furneri, P.Maria.; Piperno, A.; Sajia, A.; Bisignano, G. 2004: Antimycoplasmal activity of hydroxytyrosol. Antimicrobial Agents and ChemoTherapy 48(12): 4892-4894

Yaccoby, S.; Johnson, C.L.; Barlogie, B.; Epstein, J. 1999: Anti-myeloma efficacy of bisphosphonates in vivo. Blood 94(10 Suppl 1 Pt 1): 316a-317a

Taylor, T.V.; Itoh Linstrom, Y.; Clarke, S.H.; Jennette, J.C.; Falk, R.J.; Nachman, P.H. 2000: Anti-myeloperoxidase -derived light chain confers antibody specificity to MPO. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 483A

Steenbergen, E.J.; Heeringa, P.J.; Assmann, K.J.; Jennette, J.C.arles 2001: Anti-myeloperoxidase causes localization of MPO and anti-MPO at sites of anti-GBM glomerulonephritis, and induces increased capillary injury. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 663A

Moses, P.L.; Ellis, L.M.; Anees, R.M.; Ho, W.; Rothstein, R.; Meddings, J.B.; Sharkey, K.A.; Mawe, G.M. 2002: Anti-myenteric neuronal antibodies in achalasia and GERD Cause or effect?. Gastroenterology 122(4 Suppl 1): A-355-A-356

Fukuda, Y.kiko; Baba, Akiyasu; Yoshikawa, Tsutomu; Iwata, Michikado; Akaishi, Makoto; Mitamura, Hideo; Ogawa, Satoshi 2002: Anti-myocardial autoantibodies are found in patients with chronic lone atrial fibrillation. Circulation 106(19): 2; 409

Morgun, A.; Shulzhenko, N.; Unterkirsher, C.S.; Pereira, A.B.; Silva, M.S.; Nishida, S.K.; Almeida, D.R.; Diniz, R.V.Z.; Carvalho, A.C.C.; Franco, M.; Souza, M.M.; Gerbase Delima, M. 1999: Anti-myosin and anti-heat shock protein IgG autoantibodies in human cardiac allograft recipients. Human Immunology 60(Suppl 2): S8

Hermelin, M.S.; Kirschner, M.I.; Levinson, R.S.ul 2001: Anti-nausea compositions and methods. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Porta, C.; Imarisio, I.; Mazzoleni, F.; Bonomi, L.; Paglino, C.; Biscaldi, E.; Zimatore, M.; Mutti, L.; Danova, M. 2002: Anti-neoangiogenetic drugs and malignant mesothelioma An act of faith or a rational consequence of our increasing biological knowledge?. International Journal of Molecular Medicine 10(Suppl 1): S61

Gross, S.C.; Goodarzi, G.; Watabe, M.; Bandyopadhyay, S.; Pai, S.; Watabe, K. 2001: Anti-neoplastic activity of solidago virgaurea on prostatic tumor cells in a SCID mouse model. Proceedings of the American Association for Cancer Research 42: 190

Patel, S.; Mcarthur, J.; Gyuris, J.; Mendez, M.J.; Finer, M.H. 2003: Anti-neoplastic compositions and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1267(3)

Shawver, L.K.; Brandis, J.W.; Mann, E.; Hancock, M.E.C.; Mischak, R.P.; Monahan, J.J. 2000: Anti-neoplastic drugs in cancer therapy. Official Gazette of the United States Patent and Trademark Office Patents 1238(4)

Shao, J.; Sheng, H.; Helou, R.A.; Dubois, R.N. 2000: Anti-neoplastic effects of proteasome inhibitor MG-132. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A525

Vadgama, J.V.; Wu, Y.; Hsia, S.; Block, J. 1999: Anti-neoplastic properties of selenium in various cancers. Proceedings of the American Association for Cancer Research 40: 361

Iggo, R.; Brunori, M.A.berto 2003: Anti-neoplastic viral agents. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)

Bergeron, R.J. 2000: Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1232(1)

Bergeron, R.J. 2002: Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1256(4)

Rasaee, M.J.; Malekaneh, M. 2000: Anti-neopterin antibody. Hybridoma 19(5): 424

Oku, N.; Asai, T.; Watanabe, K.; Kuromi, K.; Ogino, K.; Taki, T. 2003: Anti-neovascular therapy by use of liposomes modified with neovessel-targeted peptide. International Journal of Molecular Medicine 12(Suppl 1): S31

Jacobs, R.S.; Pomponi, S.A.; Gunasekera, S.P.; Wright, A.E. 1999: Anti-neurogenic inflammatory compounds and compositions and methods of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)

Auten, R.L.; Mason, S.N.; Vozzelli, M.A.; Whorton, M.H.; Welty Wolf, K. 2001: Anti-neutrophil chemokine treatment ameliorates hyperoxia-induced effects on neonatal rat alveolar development. Pediatric Research 49(4 Part 2): 385A

Auten, R.L.; Whorton, M.H.; Mason, S.N. 2001: Anti-neutrophil chemokine treatment reduces hyperoxia-induced nucleic acid damage in neonatal rat bronchiolar and alveolar epithelium. Pediatric Research 49(4 Part 2): 300A

Ben Smith, A.; Dove, S.K.; Williams, J.; Hughes, P.; Wakelam, M.J.O.; Savage, C.O.S. 2000: Anti-neutrophil cytoplasm antibodies activate primed neutrophils via a Gi/o protein dependent pathway. Immunology 101(Suppl 1): 69

Hull, C.M.; Schimer, C.C.; Couser, W.G.; Knostman, J.D. 2000: Anti-neutrophil cytoplasmic antibodies Clinical and pathological comparison in Native American and Caucasian patients. Journal of Investigative Medicine 48(1): 55A

Hayes, M.; Cambridge, G. 2000: Anti-neutrophil cytoplasmic antibodies affect adhesion apoptosis and clearance of neutrophils. Clinical and Experimental Immunology 120(Suppl 1): 42

Hayes, M.J.; Cambridge, G. 1999: Anti-neutrophil cytoplasmic antibodies affect apoptosis and clearance of neutrophils. Arthritis and Rheumatism 42(9 Suppl): S316

Csernok, E. 2003: Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmunity Reviews 2(3): 158-164

Freeman, H.J. 2000: Anti-neutrophil cytoplasmic antibodies in Indo-Canadians with ulcerative colitis or Crohns disease. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A718

Subra, J.F.; Mattann, S.; Reboul, P.; Renier, G.; Chevailler, A. 2000: Anti-neutrophil cytoplasmic antibodies in silicotic patients. Clinical and Experimental Immunology 120(Suppl 1): 61

Smyth, C.L.; Pusey, C.D.; Haskard, D.O. 2003: Anti-neutrophil cytoplasmic antibodies induce adhesion of leucocytes to endothelial cells under conditions of flow. Clinical Science (London) 104(Suppl 49): 50P

Mandl, L.A.; Smith, E.L.; Lew, R.A.; Solomon, D.H.; Shmerling, R.H. 1999: Anti-neutrophil cytoplasmic antibody ordering in academic centers Patterns of use and test performance characteristics. Arthritis and Rheumatism 42(9 Suppl): S218

Mclaren, J.S.; Coia, J.E.; Mcrorie, E.R.; Luqmani, R.A. 2000: Anti-neutrophil cytoplasmic antibody requests. Clinical and Experimental Immunology 120(Suppl 1): 55

Karim, M.Y.; Frankel, A.; Paradinas, F.J.; Moss, J. 2000: Anti-neutrophil cytoplasmic antibody-positive crescentic nephritis occurring together with renal cell carcinoma. Nephron 85(4): 368-370

Ben Smith, A.; Dove, S.K.; Williams, J.; Hughes, P.; Wakelam, M.J.O.; Savage, C.O.S. 2000: Anti-neutrophil cytoplasmic autoantibodies activate primed neutrophils via a G protein dependent pathway. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 472A

Ben Smith, A.; Wakelam, M.J.O.; Savage, C.O.S. 1999: Anti-neutrophil cytoplasmic autoantibodies activate primed neutrophils via distinct signalling pathways to those elicited by cross-linking Fcgamma receptors with specific antibodies. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 507A

Pfister, H.; Ollert, M.W.; Frohlich, L.; Quintanilla Fend, L.; Specks, U.; Jenne, D.E. 2003: Anti-neutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 are pathogenic in vivo. Kidney and Blood Pressure Research 26(4): 260

Doursout, M.F.; Davidson, E.M.; Szmuk, P.; Liang, Y.Y.; Chelly, J.E. 1999: Anti-nociceptive activity of nitric oxide synthase inhibitors in the rat formalin test. Acta Physiologica Scandinavica 167(Suppl 645): 89

Kitamura, K.; Kanai, M.; Akahori, K.; Nakabayashi, M.; Takahashi, S.; Taniguchi, T.; Iwao, K.; Oka, T. 1999: Anti-nociceptive effect of dynorphin- on rats pretreated with peptidase inhibitors. Japanese Journal of Pharmacology 79(Suppl 1): 220P

Takahashi, N.; Nagano, M.; Umino, M.; Suzuki, H. 2003: Anti-nociceptive effect of glial cell line-derived neurotrophic factor in a rat model of neuropathic pain. Neuroscience Research Suppl (26): S111

Badot, V.; Servais, G.; Peretz, A. 2001: Anti-nuclear and anti-DNA antibodies in rheumatoid arthritis patient treated with Infliximab. Clinical Rheumatology 20(5): 406

Nesher, G.; Margalit, R.; Ashkenazi, Y.J. 2001: Anti-nuclear envelope antibodies: Clinical associations. Seminars in Arthritis and Rheumatism 30(5): 313-320

Us, T.; Akgun, Y.; Kanan, B. 2001: Anti-nuclear, anti-mitochondrial, anti-smooth muscle antibodies in patients with autoimmune liver disorders by indirect immunofluorescence. Allergy 56(Suppl 68): 14

Coffin, C.S.; Mulrooney, P.M.; Churchill, N.D.; Michalak, T.I. 2002: Anti-nucleocapsid antibodies circulating in the absence of other serological markers are an indicator of residual hepadnavirus replication in WHV infection. Journal of Hepatology 36(Suppl 1): 275

Fournel, S.; Decker, P.; Briand, J.P.; Muller, S. 2001: Anti-nucleosome Th cells recognized different histone H4 epitopes in normal and lupus prone mice. Lupus 10(Suppl 1): S53

Tax, W.J.M.; Berden, J.H.M. 1999: Anti-nucleosome antibodies and the pathogenesis of lupus nephritis. Journal of Autoimmunity (Suppl ): 36

Muller, S. 2001: Anti-nucleosome antibodies in systemic lupus erythematosus. Lupus 10(Suppl 1): S46

Amoura, Z.; Koutouzov, S.; Chabre, H.; Cacoub, P.; Wechsler, B.; Musset, L.; Piette, J.C. 1999: Anti-nucleosome antibodies of the IgG3 subclass are selective markers of systemic lupus erythematosus activity and renal pathogenicity. Arthritis and Rheumatism 42(9 Suppl): S100

Herraez, O.; Garcia Berrocal, B.; Gonzalez, C.; Navajo, J.A.; Gonzalez Buitrago, J.M. 2002: Anti-nucleosome, anti-dsDNA and anti-histone autoantibodies reactivity in systemic lupus erythematosus. Clinical Chemistry 48(6 Suppl): A147

Strowski, M.Z.; Air, E.; Salituro, G.M.; Liu, K.; Woods, S.C.; Zhang, B.B. 2001: Anti-obesity and insulin sensitizing effects of small molecule insulin receptor activators. Diabetes 50(Suppl 2): A275

Clapham, J.C.; Arch, J.R.; Tadayyon, M. 2001: Anti-obesity drugs: a critical review of current therapies and future opportunities. Pharmacology and Therapeutics 89(1): 81-121

Murase, T.; Hase, T.; Tokimitsu, I. 2001: Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice. FASEB Journal 15(5): A994

Takatoshi, M.; Aoki, M.; Wakisaka, T.; Hase, T.; Tokimitsu, I. 2003: Anti-obesity effect of dietary diacylglycerol in mice diacylglycerol stimulates intestinal lipid metabolism. FASEB Journal 17(4-5): Abstract 454

Sayama, K.; Lin, S.; Zheng, G.; Oguni, I. 2001: Anti-obesity effects of green tea and its three components in mice. Abstracts of Papers American Chemical Society 221(1-2): AGFD 43

Kim, S.O.; Yun, S.J.; Lim, C.Y.; Hahm, D.H.; Shim, I.; Lee, H.J.; Lee, E.H. 2003: Anti-obesity effects of oriental herbal medicines in vitro and in vivo analyses. FASEB Journal 17(4-5): Abstract 706

Zannad, F.; Ziegler, O.; Gilles, B.; Grentzinger, A.; Bruntz, J.F.; Hammadi, M.; Fluckiger, L.; Boivin, J.M.; Hanotin, C.; Drouin, P.; Gps Investigators 2000: Anti-obesity therapy with sibutramine has no clinically significant effect on cardiovascular variables, ventricular dimensions and heart valves in obese patients. American Journal of Hypertension 13(4 Part 2): 86A

Teitelbaum, G.P. 2004: Anti-occlusion catheter. Official Gazette of the United States Patent and Trademark Office Patents 1279(3)

A.S.ayeh, O.A.; Clifford, R.; Moore, P.K. 1999: Anti-oedema and antinociceptive effect of nitroprednisone and nitroflurbiprofen. British Journal of Pharmacology 127(Proceedings Suppl ): 84P

Selim, A.A.; Abdelmagid, S.M.; Kanaan, R.A.; Smock, S.L.; Owen, T.A.; Popoff, S.N.; Safadi, F.F. 2003: Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Critical Reviews in Eukaryotic Gene Expression 13(2-4): 265-275

Zhou, X.H.; Han, M.; Wen, J.K. 2002: Anti-osteopontin. Hybridoma and Hybridomics 21(3): 222

Hostrup, C.N.; Hong, K.J.; Dunn, D.; Shen, C.L.; Pence, B.C. 2003: Anti-oxidant and anti-inflammatory effects of herbal treatment Ling Zhi , on human colonic carcinoma cells. FASEB Journal 17(4-5): Abstract 457

Dillon, S.; Lowe, G.; Billington, D.; Rahman, K. 2000: Anti-oxidant and anti-platelet properties of Aged Garlic Extract. Phytomedicine 7(Suppl 2): 49

Naderi, G.A.; Asgary, S.; Sarraf Zadegan, N.; Shirvany, H.; Gharipour, M. 2001: Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation. Journal of Molecular and Cellular Cardiology 33(6): A82

Tesfay,S.Z.; Bertling,I.; Bower,J.P. 2010: Anti-oxidant levels in various tissues during the maturation of Hass avocado. Journal Of Horticultural Science And Biotechnology: 2, 106-112

Antebi, H.; Mansoor, O.; Ferrier, C.; Tetegan, M.; Morvan, C.; Rangaraj, J.; Alcindor, L.G. 2000: Anti-oxidant potential, alpha-tocopherol and retinol plasma levels in stressed patients on TPN Effects of LIPOVEN and SMOF. Clinical Nutrition 19(Suppl 1): 16

Merizzi, G. 2004: Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)

Saito, K. 2002: Anti-oxidant reducing substance and method of producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Cvetkovic, T.; Radenkovic, S.; Vlahovic, P.; Pavlovic, D.; Djordjevic, V. 2002: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 80

Stosic Grujicic, S.; Miljkovic, D.J.; Cvetkovic, I.; Maksimovic Ivanic, D.; Trajkovic, V. 2003: Anti-oxidants down-regulate the expression of proinflammatory cytokines in rat autoimmune diabetes. European Cytokine Network 14(Suppl 3): 21

JengToongLong; ShihYiJu; LaiChiaChi; WuMinTze; SungJihMin 2010: Anti-oxidative characterisation of NaN3-induced common bean mutants. Food Chemistry 9(3): 1006-1011

Komi, R.; Miwa, T.; Kanazawa, M.; Notoya, Y.; Kawai, Y.; Tnkanami, Y.; Shimomitsu, T. 2003: Anti-oxidative effect of Pioglitazone. Diabetes and Metabolism 29(Hors serie 2): 4S251

Andronis, E.A.; Papadakis, A.K.; Roubelakis Angelakis, K.A. 2003: Anti-oxidative mechanisms response to salinity stress in Nicotiana tabacum plants and leaf discs. Free Radical Research 37(Suppl 2): 33

Tao, L.; Liu, H.; Gao, E.; Christopher, T.; Lopez, B.; Willette, R.; Ohlstein, E.; Yue, T.; Ma, X. 2003: Anti-oxidative, anti-nitrosative and vascularprotective effects of a Peroxisome Proliferator-Activated Receptor-gamma agonist in hypercholesterolemia. Circulation 108(17): IV282

Monaco, C.; Niccoli, G.; Summaria, F.; Bordone, R.; Beliomo, G.; Crea, F. 2000: Anti-oxidized LDL antibodies levels in patients with stable angina, unstable angina and peripheral vascular disease Pathophysiological implications. European Heart Journal 21(Abstract Suppl): 655

Hayem, Gilles; Nicaise, Pascale; De Bandt, Michel; Palazzo, Elisabeth; Laine, Pascale; Meyer, Olivier 2000: Anti-oxidized-low density-lipoprotein antibodies in primary and secondary antiphospholipid syndrome. Journal of Autoimmunity 15(2): A42

Bozorgi, K.; Pusztai, L.; Dalrymple, J.L.; Mcwatter, A.; Mills, G.B.; Bast, R.C.Jr 1999: Anti-p185cerbB-2-ricin-A-chain-immunotoxin induces p53-independent apoptosis by preferentially inhibiting antiapoptotic protein expression. Gynecologic Oncology 72(3): 509-510

Debendetti, V.M.G.; Trivers, G.; Cawley, H.; Rehfuss, M.; Pilotti, S.; Harris, C.C.; Foremllii, F. 1999: Anti-p53 antibodies in plasma from state 1 breast cancer patients from the phase III fenretinide prevention trial. Proceedings of the American Association for Cancer Research 40: 704

Filiberti, R.; Paganuzzi, M.; Neri, M.; Cafferata, M.; Marroni, P.; Ivaldi, G.P.; Betta, P.G.; Canessa, A.; Verna, A.; Puntoni, R. 2001: Anti-p53 autoantibodies and PDGF A-B in serum of pleural mesotheliomas, lung cancers and controls. Proceedings of the American Association for Cancer Research 42: 151

Di Cesare, E.; Previti, M.; Lombardo, F.; Di Benedetto, A.; Romano, G.; De Luca, F.; Cucinotta, D. 1999: Anti-p53 autoantibodies in patients with IDDM. Diabetologia 42(Suppl 1): A97

Riegler, G.; Cioffi, M.; Tartaglione, M.T.; Caserta, L.; Vietri, M.T.; Gazzerro, P.; De Lisa, F.; Carratu, R.; Puca, G.; Molinari, A.M. 2000: Anti-p53 serum antibodies A new strategy for improving colorectal cancer surveillance in ulcerative colitis. Digestive and Liver Disease 32(Suppl 1): A12

Vermeire, S.; Norman, G.; Dufresne, L.; Cousineau, J.; Ghandi, Z.; Pellerin, N.; Bernier, M.L.; Bitton, A.; Wild, G. 2002: Anti-pancreatic and anti-Saccharomyces cerevisiae antibodies in Crohns disease in Quebec. Gastroenterology 122(4 Suppl 1): A-176